| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 4.32e-09 | 37 | 133 | 7 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 5.27e-09 | 38 | 133 | 7 | GO:0070001 | |
| GeneOntologyMolecularFunction | structural constituent of nuclear pore | 5.80e-07 | 25 | 133 | 5 | GO:0017056 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 5.99e-07 | 11 | 133 | 4 | GO:0004523 | |
| GeneOntologyMolecularFunction | nuclear localization sequence binding | 8.72e-07 | 27 | 133 | 5 | GO:0008139 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 1.79e-06 | 14 | 133 | 4 | GO:0003964 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 1.03e-05 | 21 | 133 | 4 | GO:0035613 | |
| GeneOntologyMolecularFunction | transcription factor binding | MAGEA11 AKAP8 PPRC1 LMO4 CREBBP MEF2C MEF2D JUN LATS1 NFATC3 BAZ2A TLE1 ARID2 EIF4E NCOA1 TAF4B TBP | 1.09e-05 | 753 | 133 | 17 | GO:0008134 |
| GeneOntologyMolecularFunction | signal sequence binding | 2.23e-05 | 51 | 133 | 5 | GO:0005048 | |
| GeneOntologyMolecularFunction | structural molecule activity | ERVK-6 HSPG2 COL15A1 MAP1A POM121L2 ERVK-7 ERVK-9 ERVK-10 NUP58 POM121C PGM5 ZP1 POM121 DST ERVK-8 ERVK-19 ERVK-24 POM121B | 2.61e-05 | 891 | 133 | 18 | GO:0005198 |
| GeneOntologyMolecularFunction | chromatin binding | ZNF609 AKAP8 TOX NRL NELFA TSPY4 TSPY9 CREBBP MEF2C JUN TOX4 NFATC3 TRIM28 TLE1 BRD4 NCOA1 | 3.34e-05 | 739 | 133 | 16 | GO:0003682 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | MAGEA11 AKAP8 LMO4 CREBBP MEF2C MEF2D JUN LATS1 BAZ2A TLE1 EIF4E NCOA1 TAF4B TBP | 3.46e-05 | 582 | 133 | 14 | GO:0140297 |
| GeneOntologyMolecularFunction | methyl-CpG binding | 5.15e-05 | 31 | 133 | 4 | GO:0008327 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 1.05e-04 | 37 | 133 | 4 | GO:0016891 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 1.16e-04 | 38 | 133 | 4 | GO:0034061 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 2.47e-04 | 46 | 133 | 4 | GO:0016893 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 4.88e-04 | 417 | 133 | 10 | GO:0061629 | |
| GeneOntologyMolecularFunction | TFIIB-class transcription factor binding | 6.49e-04 | 6 | 133 | 2 | GO:0001093 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | MAP1A PPRC1 NELFA KSR2 IRAK2 MED13L LMO4 SRCAP CREBBP GAB2 KMT2D BAZ2A TRIM28 TLE1 BRD4 MDC1 PDE4DIP TCF25 NCOA1 DGCR8 | 6.50e-04 | 1356 | 133 | 20 | GO:0060090 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | MAP1A PPRC1 KSR2 IRAK2 MED13L LMO4 SRCAP CREBBP GAB2 KMT2D BAZ2A TRIM28 TLE1 BRD4 MDC1 TCF25 NCOA1 DGCR8 | 6.92e-04 | 1160 | 133 | 18 | GO:0030674 |
| GeneOntologyMolecularFunction | dicarboxylic acid transmembrane transporter activity | 1.13e-03 | 31 | 133 | 3 | GO:0005310 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | PPRC1 MED13L LMO4 SRCAP CREBBP KMT2D TRIM28 TLE1 BRD4 TCF25 NCOA1 | 1.36e-03 | 562 | 133 | 11 | GO:0003712 |
| GeneOntologyMolecularFunction | peptidase activity | ERVK-6 FOLH1 ERVK-7 ERVK-9 ERVK-10 USP19 TPSD1 ERVK-8 ERVK-19 USP54 ERVK-24 MMP14 | 1.43e-03 | 654 | 133 | 12 | GO:0008233 |
| GeneOntologyMolecularFunction | oxalate transmembrane transporter activity | 1.91e-03 | 10 | 133 | 2 | GO:0019531 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 1.92e-03 | 79 | 133 | 4 | GO:0004521 | |
| GeneOntologyMolecularFunction | RNA polymerase I core promoter sequence-specific DNA binding | 2.33e-03 | 11 | 133 | 2 | GO:0001164 | |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-6 ERVK-7 ERVK-9 ERVK-10 TPSD1 ERVK-8 ERVK-19 ERVK-24 MMP14 | 2.38e-03 | 430 | 133 | 9 | GO:0004175 |
| GeneOntologyMolecularFunction | chromatin-protein adaptor activity | 2.56e-03 | 41 | 133 | 3 | GO:0140463 | |
| GeneOntologyMolecularFunction | RNA polymerase I transcription regulatory region sequence-specific DNA binding | 3.27e-03 | 13 | 133 | 2 | GO:0001163 | |
| GeneOntologyMolecularFunction | chloride:bicarbonate antiporter activity | 3.27e-03 | 13 | 133 | 2 | GO:0140900 | |
| GeneOntologyMolecularFunction | bicarbonate:monoatomic anion antiporter activity | 3.27e-03 | 13 | 133 | 2 | GO:0140829 | |
| GeneOntologyBiologicalProcess | DNA integration | 1.10e-06 | 13 | 132 | 4 | GO:0015074 | |
| GeneOntologyBiologicalProcess | DNA methylation-dependent constitutive heterochromatin formation | 8.84e-06 | 44 | 132 | 5 | GO:0006346 | |
| GeneOntologyBiologicalProcess | viral process | ERVK-6 ERVK-7 ERVK-9 ERVK-10 CREBBP PIKFYVE JUN TRIM28 BRD4 ERVK-8 ERVK-19 ERVK-24 UVRAG | 9.06e-06 | 464 | 132 | 13 | GO:0016032 |
| GeneOntologyBiologicalProcess | RNA transport | 1.72e-05 | 175 | 132 | 8 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 1.72e-05 | 175 | 132 | 8 | GO:0050657 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 1.95e-05 | 178 | 132 | 8 | GO:0051236 | |
| GeneOntologyBiologicalProcess | protein localization to nucleus | POM121L2 NUP58 POM121C CREBBP PIKFYVE LATS1 POM121 DCP1B NFATC3 TRIM28 POM121B | 2.18e-05 | 362 | 132 | 11 | GO:0034504 |
| GeneOntologyBiologicalProcess | facultative heterochromatin formation | 2.68e-05 | 55 | 132 | 5 | GO:0140718 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | ERVK-6 POM121L2 NUP58 POM121C EPG5 POM121 ATXN2 EIF4E POM121B | 3.29e-05 | 249 | 132 | 9 | GO:0015931 |
| GeneOntologyBiologicalProcess | RNA export from nucleus | 3.55e-05 | 96 | 132 | 6 | GO:0006405 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | MBD3L5 ARID4B TOX TSPY4 TSPY9 MBD3L3 MBD3L4 SRCAP CREBBP KMT2D BAZ2A TRIM28 ARID2 BRD4 MDC1 NCOA1 TAF4B TBP | 6.85e-05 | 999 | 132 | 18 | GO:0071824 |
| GeneOntologyBiologicalProcess | RNA localization | 7.95e-05 | 217 | 132 | 8 | GO:0006403 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | MBD3L5 MAGEA11 ARID4B ZBTB4 MBD3L3 MBD3L4 LMO4 CREBBP ZEB2 MEF2C JUN METTL13 KLF10 NFATC3 TRIM28 TLE1 TCF25 HSF4 | 1.33e-04 | 1053 | 132 | 18 | GO:0000122 |
| GeneOntologyBiologicalProcess | replacement ossification | 1.63e-04 | 43 | 132 | 4 | GO:0036075 | |
| GeneOntologyBiologicalProcess | endochondral ossification | 1.63e-04 | 43 | 132 | 4 | GO:0001958 | |
| GeneOntologyBiologicalProcess | nuclear pore organization | 1.95e-04 | 18 | 132 | 3 | GO:0006999 | |
| GeneOntologyBiologicalProcess | chromatin organization | MBD3L5 ARID4B TOX TSPY4 TSPY9 MBD3L3 MBD3L4 SRCAP CREBBP KMT2D BAZ2A TRIM28 ARID2 BRD4 MDC1 NCOA1 | 1.98e-04 | 896 | 132 | 16 | GO:0006325 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | ZNF609 ARID4B TOX NRL PPRC1 NELFA LMO4 CREBBP ZEB2 MEF2C MEF2D JUN KMT2D KLF10 NFATC3 ARID2 BRD4 MDC1 NCOA1 TAF4B TBP | 1.98e-04 | 1390 | 132 | 21 | GO:0045944 |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 2.51e-04 | 48 | 132 | 4 | GO:0000731 | |
| GeneOntologyBiologicalProcess | protein import into nucleus | 2.64e-04 | 195 | 132 | 7 | GO:0006606 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | MBD3L5 ARID4B TSPY4 TSPY9 MBD3L3 MBD3L4 SRCAP CREBBP KMT2D BAZ2A TRIM28 ARID2 BRD4 NCOA1 | 2.88e-04 | 741 | 132 | 14 | GO:0006338 |
| GeneOntologyBiologicalProcess | import into nucleus | 3.17e-04 | 201 | 132 | 7 | GO:0051170 | |
| GeneOntologyBiologicalProcess | mRNA transport | 3.44e-04 | 145 | 132 | 6 | GO:0051028 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol-3-phosphate biosynthetic process | 3.61e-04 | 22 | 132 | 3 | GO:0036092 | |
| GeneOntologyBiologicalProcess | retrograde axonal transport | 4.70e-04 | 24 | 132 | 3 | GO:0008090 | |
| GeneOntologyBiologicalProcess | neuron projection development | HSPG2 TOX MAP1A MPDZ PLXND1 LMO4 GPRIN1 ZNF804A CREBBP DSCAML1 ZEB2 MEF2C JUN NRXN3 DST ATXN2 TMEM108 CAMSAP1 SEZ6 | 5.37e-04 | 1285 | 132 | 19 | GO:0031175 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | ESS2 ARID4B NELFA RBM42 POM121L2 NUP58 MED13L LMO4 SRCAP POM121C KHDC4 CREBBP JUN KMT2D POM121 BAZ2A TRIM28 TLE1 ARID2 BRD4 NCOA1 DGCR8 TAF4B POM121B UVRAG TBP | 4.19e-07 | 1377 | 132 | 26 | GO:0140513 |
| GeneOntologyCellularComponent | chromatin | AKAP8 ARID4B NRL TSPY4 TSPY9 SRCAP CREBBP ZEB2 MEF2C MEF2D JUN TOX4 KLF10 NFATC3 BAZ2A TRIM28 ARID2 BRD4 NCOA1 HSFX1 HSF4 TBP | 1.43e-04 | 1480 | 132 | 22 | GO:0000785 |
| GeneOntologyCellularComponent | dendritic microtubule | 2.35e-04 | 4 | 132 | 2 | GO:1901588 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 3.40e-04 | 272 | 132 | 8 | GO:0090575 | |
| GeneOntologyCellularComponent | subapical complex | 3.91e-04 | 5 | 132 | 2 | GO:0035003 | |
| GeneOntologyCellularComponent | nuclear pore | 4.54e-04 | 101 | 132 | 5 | GO:0005643 | |
| GeneOntologyCellularComponent | nuclear body | MAGEA11 NELFA ZBTB4 PATL1 CMYA5 SRCAP CREBBP MEF2C ZNF106 BAZ2A MDC1 EIF4E DGCR8 HSF4 SH3BP5 | 5.87e-04 | 903 | 132 | 15 | GO:0016604 |
| HumanPheno | Abnormality of mouth shape | HSPG2 ESS2 NELFA PLXND1 MED13L SRCAP ZEB2 MEF2C KMT2D DST BRD4 DGCR8 | 7.63e-07 | 294 | 38 | 12 | HP:0011338 |
| HumanPheno | Premature thelarche | 5.85e-06 | 17 | 38 | 4 | HP:0010314 | |
| HumanPheno | Abnormal anterior eye segment morphology | HSPG2 ESS2 NRL NELFA WDR81 MPDZ PLXND1 MED13L SRCAP CREBBP ZEB2 EPG5 PIKFYVE KMT2D DST CEP120 PIK3C2A TRIM28 BRD4 DGCR8 CAMSAP1 MMP14 HSF4 ALDH6A1 | 8.37e-06 | 1450 | 38 | 24 | HP:0004328 |
| HumanPheno | Interrupted aortic arch | 1.75e-05 | 22 | 38 | 4 | HP:0011611 | |
| HumanPheno | Abnormal ventriculoarterial connection | 2.57e-05 | 280 | 38 | 10 | HP:0011563 | |
| HumanPheno | Open mouth | 2.88e-05 | 124 | 38 | 7 | HP:0000194 | |
| HumanPheno | Abnormal connection of the cardiac segments | 2.90e-05 | 284 | 38 | 10 | HP:0011545 | |
| HumanPheno | Tetralogy of Fallot | 4.99e-05 | 185 | 38 | 8 | HP:0001636 | |
| HumanPheno | Cerebellar Purkinje layer atrophy | 5.42e-05 | 2 | 38 | 2 | HP:0012082 | |
| HumanPheno | Abnormal cardiac septum morphology | HSPG2 ESS2 NELFA MPDZ PLXND1 MED13L SRCAP CREBBP ZEB2 EPG5 KMT2D DST ARID2 BRD4 DGCR8 MMP14 | 7.05e-05 | 787 | 38 | 16 | HP:0001671 |
| HumanPheno | Complex cardiac malformations | 8.26e-05 | 257 | 38 | 9 | HP:0002565 | |
| HumanPheno | Abnormal branching pattern of the aortic arch | 9.23e-05 | 33 | 38 | 4 | HP:0011587 | |
| HumanPheno | Conotruncal defect | 1.02e-04 | 264 | 38 | 9 | HP:0001710 | |
| HumanPheno | Pulmonary artery atresia | 1.04e-04 | 34 | 38 | 4 | HP:0004935 | |
| HumanPheno | Abnormal aortic arch morphology | 1.32e-04 | 109 | 38 | 6 | HP:0012303 | |
| HumanPheno | Hirsutism | 1.49e-04 | 216 | 38 | 8 | HP:0001007 | |
| HumanPheno | Narrow palpebral fissure | 1.60e-04 | 71 | 38 | 5 | HP:0045025 | |
| HumanPheno | Low posterior hairline | 1.96e-04 | 117 | 38 | 6 | HP:0002162 | |
| HumanPheno | Abnormality of the posterior hairline | 1.96e-04 | 117 | 38 | 6 | HP:0030141 | |
| HumanPheno | Hernia | HSPG2 ESS2 NELFA MED13L SRCAP CREBBP KMT2D CEP120 ARID2 BRD4 DGCR8 CAMSAP1 MMP14 | 2.00e-04 | 589 | 38 | 13 | HP:0100790 |
| HumanPheno | Abnormality of the hairline | 2.32e-04 | 294 | 38 | 9 | HP:0009553 | |
| HumanPheno | Cryptorchidism | HSPG2 ESS2 NELFA MED13L SRCAP CREBBP ZEB2 KMT2D CEP120 PIK3C2A TRIM28 ARID2 BRD4 DGCR8 CAMSAP1 | 2.54e-04 | 780 | 38 | 15 | HP:0000028 |
| HumanPheno | Congenital malformation of the great arteries | HSPG2 ESS2 PLXND1 MED13L SRCAP CREBBP ZEB2 KMT2D CEP120 ARID2 DGCR8 MMP14 | 2.98e-04 | 529 | 38 | 12 | HP:0011603 |
| HumanPheno | Abnormality of dental eruption | 3.09e-04 | 240 | 38 | 8 | HP:0006292 | |
| HumanPheno | Hypospadias | 3.15e-04 | 377 | 38 | 10 | HP:0000047 | |
| HumanPheno | Abnormal lateral ventricle morphology | 3.33e-04 | 129 | 38 | 6 | HP:0030047 | |
| HumanPheno | Atrial septal defect | NELFA MPDZ PLXND1 MED13L SRCAP CREBBP ZEB2 EPG5 KMT2D ARID2 BRD4 MMP14 | 3.68e-04 | 541 | 38 | 12 | HP:0001631 |
| HumanPheno | Abnormality of the atrial septum | NELFA MPDZ PLXND1 MED13L SRCAP CREBBP ZEB2 EPG5 KMT2D ARID2 BRD4 MMP14 | 3.68e-04 | 541 | 38 | 12 | HP:0001630 |
| HumanPheno | Abnormal nasal tip morphology | 3.82e-04 | 386 | 38 | 10 | HP:0000436 | |
| HumanPheno | Abnormal atrial septum morphology | NELFA MPDZ PLXND1 MED13L SRCAP CREBBP ZEB2 EPG5 KMT2D ARID2 BRD4 MMP14 | 3.87e-04 | 544 | 38 | 12 | HP:0011994 |
| HumanPheno | Abnormal external nose morphology | HSPG2 ESS2 MPDZ MED13L SRCAP CREBBP ZEB2 MEF2C EPG5 KMT2D CEP120 PIK3C2A ARID2 BRD4 DGCR8 ALDH6A1 | 4.43e-04 | 916 | 38 | 16 | HP:0010938 |
| HumanPheno | Dysplastic corpus callosum | HSPG2 NELFA MPDZ CREBBP ZEB2 EPG5 CEP120 PIK3C2A ARID2 CAMSAP1 | 4.60e-04 | 395 | 38 | 10 | HP:0006989 |
| HumanPheno | Displacement of the urethral meatus | 4.79e-04 | 397 | 38 | 10 | HP:0100627 | |
| HumanPheno | Abnormal testis morphology | HSPG2 ESS2 NRL NELFA MED13L SRCAP CREBBP ZEB2 KMT2D CEP120 PIK3C2A TRIM28 ARID2 BRD4 DGCR8 TAF4B CAMSAP1 SPAG17 | 4.98e-04 | 1129 | 38 | 18 | HP:0000035 |
| HumanPheno | Abnormal male urethral meatus morphology | 4.99e-04 | 399 | 38 | 10 | HP:0032076 | |
| HumanPheno | Congenital abnormal hair pattern | 5.13e-04 | 327 | 38 | 9 | HP:0011361 | |
| HumanPheno | Non-obstructive azoospermia | HSPG2 ESS2 NRL NELFA MED13L SRCAP CREBBP ZEB2 KMT2D CEP120 PIK3C2A TRIM28 ARID2 BRD4 DGCR8 TAF4B CAMSAP1 SPAG17 | 5.15e-04 | 1132 | 38 | 18 | HP:0011961 |
| HumanPheno | Aplasia/Hypoplasia involving the nose | ESS2 MED13L SRCAP CREBBP MEF2C KMT2D ARID2 BRD4 DGCR8 ALDH6A1 | 5.19e-04 | 401 | 38 | 10 | HP:0009924 |
| HumanPheno | Unilateral primary pulmonary dysgenesis | 5.34e-04 | 5 | 38 | 2 | HP:0006549 | |
| HumanPheno | Abnormal male internal genitalia morphology | HSPG2 ESS2 NRL NELFA SLC26A9 MED13L SRCAP CREBBP ZEB2 KMT2D CEP120 PIK3C2A TRIM28 ARID2 BRD4 DGCR8 TAF4B CAMSAP1 SPAG17 | 5.39e-04 | 1243 | 38 | 19 | HP:0000022 |
| HumanPheno | Abnormal thought pattern | 5.51e-04 | 404 | 38 | 10 | HP:5200269 | |
| HumanPheno | Abnormal cornea morphology | HSPG2 ESS2 NRL NELFA PLXND1 CREBBP ZEB2 PIKFYVE KMT2D DST BRD4 DGCR8 CAMSAP1 MMP14 | 5.67e-04 | 744 | 38 | 14 | HP:0000481 |
| HumanPheno | Bulbous nose | 5.97e-04 | 201 | 38 | 7 | HP:0000414 | |
| HumanPheno | Low anterior hairline | 6.71e-04 | 147 | 38 | 6 | HP:0000294 | |
| HumanPheno | Azoospermia | HSPG2 ESS2 NRL NELFA MED13L SRCAP CREBBP ZEB2 KMT2D CEP120 PIK3C2A TRIM28 ARID2 BRD4 DGCR8 TAF4B CAMSAP1 SPAG17 | 6.82e-04 | 1157 | 38 | 18 | HP:0000027 |
| HumanPheno | Abnormal columella morphology | 6.89e-04 | 97 | 38 | 5 | HP:0009929 | |
| HumanPheno | Paranoia | 6.96e-04 | 24 | 38 | 3 | HP:0011999 | |
| HumanPheno | Low hanging columella | 7.33e-04 | 56 | 38 | 4 | HP:0009765 | |
| HumanPheno | Abnormal internal genitalia | HSPG2 ESS2 NRL NELFA SLC26A9 MED13L SRCAP CREBBP ZEB2 KMT2D CEP120 PIK3C2A TRIM28 ARID2 BRD4 DGCR8 TAF4B CAMSAP1 SPAG17 MMP14 GP1BA | 7.35e-04 | 1498 | 38 | 21 | HP:0000812 |
| HumanPheno | Abnormal anterior chamber morphology | HSPG2 NRL NELFA MED13L SRCAP ZEB2 EPG5 KMT2D PIK3C2A TRIM28 HSF4 | 7.48e-04 | 500 | 38 | 11 | HP:0000593 |
| HumanPheno | Coloboma | 7.53e-04 | 274 | 38 | 8 | HP:0000589 | |
| HumanPheno | Hernia of the abdominal wall | HSPG2 ESS2 MED13L SRCAP CREBBP KMT2D CEP120 BRD4 DGCR8 CAMSAP1 MMP14 | 8.28e-04 | 506 | 38 | 11 | HP:0004299 |
| HumanPheno | Aplasia/Hypoplasia of the corpus callosum | HSPG2 NELFA WDR81 MPDZ CREBBP ZEB2 MEF2C EPG5 KMT2D CEP120 ARID2 BRD4 CAMSAP1 ALDH6A1 | 8.30e-04 | 772 | 38 | 14 | HP:0007370 |
| HumanPheno | Ventricular septal defect | ESS2 PLXND1 MED13L CREBBP ZEB2 KMT2D DST ARID2 BRD4 DGCR8 MMP14 | 8.85e-04 | 510 | 38 | 11 | HP:0001629 |
| HumanPheno | Right aortic arch | 8.85e-04 | 26 | 38 | 3 | HP:0012020 | |
| HumanPheno | Abnormality of the frontal hairline | 8.92e-04 | 215 | 38 | 7 | HP:0000599 | |
| HumanPheno | Abdominal wall defect | HSPG2 ESS2 MED13L SRCAP CREBBP KMT2D CEP120 BRD4 DGCR8 CAMSAP1 MMP14 | 8.99e-04 | 511 | 38 | 11 | HP:0010866 |
| HumanPheno | Thoracoabdominal wall defect | HSPG2 ESS2 MED13L SRCAP CREBBP KMT2D CEP120 BRD4 DGCR8 CAMSAP1 MMP14 | 8.99e-04 | 511 | 38 | 11 | HP:0100656 |
| HumanPheno | Underdeveloped nasal alae | 9.46e-04 | 104 | 38 | 5 | HP:0000430 | |
| HumanPheno | Abnormal spermatogenesis | HSPG2 ESS2 NRL NELFA MED13L SRCAP CREBBP ZEB2 KMT2D CEP120 PIK3C2A TRIM28 ARID2 BRD4 DGCR8 TAF4B CAMSAP1 SPAG17 | 9.74e-04 | 1190 | 38 | 18 | HP:0008669 |
| HumanPheno | Abnormality of T cell physiology | 1.01e-03 | 61 | 38 | 4 | HP:0011840 | |
| HumanPheno | Abnormal ventricular septum morphology | ESS2 PLXND1 MED13L CREBBP ZEB2 KMT2D DST ARID2 BRD4 DGCR8 MMP14 | 1.06e-03 | 521 | 38 | 11 | HP:0010438 |
| HumanPheno | Abnormal aortic morphology | 1.09e-03 | 363 | 38 | 9 | HP:0030963 | |
| HumanPheno | Depressed nasal tip | 1.10e-03 | 28 | 38 | 3 | HP:0000437 | |
| HumanPheno | Unicoronal synostosis | 1.11e-03 | 7 | 38 | 2 | HP:0011315 | |
| HumanPheno | Right aortic arch with mirror image branching | 1.11e-03 | 7 | 38 | 2 | HP:0002627 | |
| HumanPheno | Agenesis of corpus callosum | 1.14e-03 | 365 | 38 | 9 | HP:0001274 | |
| HumanPheno | Epicanthus | HSPG2 NELFA PLXND1 MED13L SRCAP CREBBP ZEB2 EPG5 KMT2D PIK3C2A ARID2 ALDH6A1 | 1.17e-03 | 614 | 38 | 12 | HP:0000286 |
| HumanPheno | Short 5th finger | 1.21e-03 | 64 | 38 | 4 | HP:0009237 | |
| HumanPheno | Abnormal cardiac atrium morphology | NELFA MPDZ PLXND1 MED13L SRCAP CREBBP ZEB2 EPG5 KMT2D ARID2 BRD4 MMP14 | 1.22e-03 | 617 | 38 | 12 | HP:0005120 |
| HumanPheno | Abnormality of the male genitalia | HSPG2 ESS2 NRL NELFA SLC26A9 MED13L SRCAP CREBBP ZEB2 EPG5 KMT2D CEP120 PIK3C2A TRIM28 ARID2 BRD4 DGCR8 TAF4B CAMSAP1 SPAG17 | 1.24e-03 | 1437 | 38 | 20 | HP:0010461 |
| HumanPheno | Abnormal male external genitalia morphology | HSPG2 ESS2 NRL NELFA MED13L SRCAP CREBBP ZEB2 EPG5 KMT2D CEP120 PIK3C2A TRIM28 ARID2 BRD4 DGCR8 TAF4B CAMSAP1 SPAG17 | 1.31e-03 | 1329 | 38 | 19 | HP:0000032 |
| HumanPheno | Abnormal dental morphology | 1.33e-03 | 299 | 38 | 8 | HP:0006482 | |
| HumanPheno | Aplasia/Hypoplasia of the 5th finger | 1.36e-03 | 66 | 38 | 4 | HP:0006262 | |
| HumanPheno | Abnormal nasal septum morphology | 1.49e-03 | 115 | 38 | 5 | HP:0000419 | |
| HumanPheno | Weak voice | 1.49e-03 | 31 | 38 | 3 | HP:0001621 | |
| Domain | MeCpG-bd_2/3_C_dom | 9.11e-06 | 7 | 121 | 3 | IPR025884 | |
| Domain | MBD2/MBD3_p55-bd | 9.11e-06 | 7 | 121 | 3 | IPR032343 | |
| Domain | MBDa | 9.11e-06 | 7 | 121 | 3 | PF16564 | |
| Domain | MBD_C | 9.11e-06 | 7 | 121 | 3 | PF14048 | |
| Domain | L27_2 | 4.16e-05 | 2 | 121 | 2 | PF09045 | |
| Domain | L27_2 | 4.16e-05 | 2 | 121 | 2 | IPR015132 | |
| Domain | BROMODOMAIN_1 | 9.38e-05 | 37 | 121 | 4 | PS00633 | |
| Domain | BROMODOMAIN_2 | 1.41e-04 | 41 | 121 | 4 | PS50014 | |
| Domain | Bromodomain | 1.55e-04 | 42 | 121 | 4 | IPR001487 | |
| Domain | BROMO | 1.55e-04 | 42 | 121 | 4 | SM00297 | |
| Domain | - | 1.55e-04 | 42 | 121 | 4 | 1.20.920.10 | |
| Domain | HJURP_C | 2.48e-04 | 4 | 121 | 2 | IPR022102 | |
| Domain | MADS_MEF2-like | 2.48e-04 | 4 | 121 | 2 | IPR033896 | |
| Domain | HJURP_C | 2.48e-04 | 4 | 121 | 2 | PF12347 | |
| Domain | Znf_FYVE_PHD | 3.92e-04 | 147 | 121 | 6 | IPR011011 | |
| Domain | MADS_BOX_1 | 6.14e-04 | 6 | 121 | 2 | PS00350 | |
| Domain | Nuc_rcpt_coact | 6.14e-04 | 6 | 121 | 2 | IPR009110 | |
| Domain | MADS | 6.14e-04 | 6 | 121 | 2 | SM00432 | |
| Domain | SRF-TF | 6.14e-04 | 6 | 121 | 2 | PF00319 | |
| Domain | MADS_BOX_2 | 6.14e-04 | 6 | 121 | 2 | PS50066 | |
| Domain | Bromodomain_CS | 6.18e-04 | 26 | 121 | 3 | IPR018359 | |
| Domain | TF_MADSbox | 8.56e-04 | 7 | 121 | 2 | IPR002100 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 7.13e-06 | 43 | 89 | 5 | MM14609 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 1.52e-05 | 50 | 89 | 5 | MM14610 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS | 2.43e-05 | 55 | 89 | 5 | M27145 | |
| Pathway | REACTOME_HIV_LIFE_CYCLE | 4.27e-05 | 149 | 89 | 7 | M4076 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 7.49e-05 | 36 | 89 | 4 | M26974 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.14e-04 | 40 | 89 | 4 | MM14945 | |
| Pathway | REACTOME_INFECTIOUS_DISEASE | HSPG2 ARID4B NELFA IRAK2 NUP58 MED13L POM121C CREBBP ITPR2 LIG1 JUN POM121 TRIM28 BRD4 TAF4B PATJ UVRAG TBP | 1.19e-04 | 1081 | 89 | 18 | M27548 |
| Pathway | REACTOME_VIRAL_INFECTION_PATHWAYS | HSPG2 ARID4B NELFA IRAK2 NUP58 MED13L POM121C CREBBP LIG1 POM121 TRIM28 BRD4 TAF4B PATJ UVRAG TBP | 1.23e-04 | 888 | 89 | 16 | M48034 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 1.26e-04 | 41 | 89 | 4 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 1.38e-04 | 42 | 89 | 4 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 1.52e-04 | 43 | 89 | 4 | M26975 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 1.87e-04 | 84 | 89 | 5 | MM14929 | |
| Pathway | REACTOME_SUMOYLATION | 1.90e-04 | 189 | 89 | 7 | M27214 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 2.09e-04 | 86 | 89 | 5 | MM15413 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 2.15e-04 | 47 | 89 | 4 | MM14939 | |
| Pathway | WP_ENERGY_METABOLISM | 2.34e-04 | 48 | 89 | 4 | M39590 | |
| Pathway | REACTOME_HEME_SIGNALING | 2.53e-04 | 49 | 89 | 4 | M41832 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 2.53e-04 | 49 | 89 | 4 | MM14837 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 2.96e-04 | 51 | 89 | 4 | MM15151 | |
| Pathway | REACTOME_SARS_COV_2_HOST_INTERACTIONS | 3.03e-04 | 204 | 89 | 7 | M45011 | |
| Pathway | REACTOME_MITOCHONDRIAL_BIOGENESIS | 3.48e-04 | 96 | 89 | 5 | M26973 | |
| Pathway | WP_B_CELL_RECEPTOR_SIGNALING | 3.66e-04 | 97 | 89 | 5 | M39323 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 3.96e-04 | 55 | 89 | 4 | MM14917 | |
| Pathway | WP_IL6_SIGNALING_PATHWAY | 4.21e-04 | 100 | 89 | 5 | MM15826 | |
| Pathway | REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION | 4.47e-04 | 24 | 89 | 3 | MM15658 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 4.86e-04 | 58 | 89 | 4 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 4.86e-04 | 58 | 89 | 4 | MM14736 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 5.69e-04 | 26 | 89 | 3 | M2499 | |
| Pathway | REACTOME_SARS_COV_2_INFECTION | 5.95e-04 | 299 | 89 | 8 | M41727 | |
| Pathway | REACTOME_HIV_INFECTION | 6.39e-04 | 231 | 89 | 7 | M12469 | |
| Pathway | REACTOME_SUMOYLATION | 6.94e-04 | 169 | 89 | 6 | MM14919 | |
| Pathway | PID_RB_1PATHWAY | 7.49e-04 | 65 | 89 | 4 | M279 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 7.49e-04 | 65 | 89 | 4 | MM15147 | |
| Pathway | REACTOME_SARS_COV_INFECTIONS | HSPG2 ARID4B IRAK2 NUP58 POM121C CREBBP POM121 BRD4 PATJ UVRAG | 7.55e-04 | 471 | 89 | 10 | M39009 |
| Pathway | BIOCARTA_RARRXR_PATHWAY | 8.11e-04 | 7 | 89 | 2 | M6907 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 9.91e-04 | 70 | 89 | 4 | M938 | |
| Pathway | WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR | 1.06e-03 | 32 | 89 | 3 | M39521 | |
| Pathway | REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN | 1.06e-03 | 32 | 89 | 3 | M29579 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 1.08e-03 | 8 | 89 | 2 | M22058 | |
| Pathway | REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS | 1.16e-03 | 33 | 89 | 3 | M27016 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 1.16e-03 | 73 | 89 | 4 | MM14948 | |
| Pathway | REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES | 1.20e-03 | 126 | 89 | 5 | M45009 | |
| Pathway | REACTOME_ISG15_ANTIVIRAL_MECHANISM | 1.22e-03 | 74 | 89 | 4 | M48006 | |
| Pathway | REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN | 1.26e-03 | 34 | 89 | 3 | M27041 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 1.38e-03 | 35 | 89 | 3 | M27320 | |
| Pathway | BIOCARTA_PCAF_PATHWAY | 1.38e-03 | 9 | 89 | 2 | MM1533 | |
| Pathway | REACTOME_MULTIFUNCTIONAL_ANION_EXCHANGERS | 1.38e-03 | 9 | 89 | 2 | M27344 | |
| Pathway | REACTOME_MULTIFUNCTIONAL_ANION_EXCHANGERS | 1.38e-03 | 9 | 89 | 2 | MM15084 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 1.41e-03 | 77 | 89 | 4 | M27226 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.49e-03 | 36 | 89 | 3 | M27245 | |
| Pathway | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | 1.62e-03 | 37 | 89 | 3 | M1029 | |
| Pathway | REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS | 1.62e-03 | 37 | 89 | 3 | M27038 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE | 1.72e-03 | 10 | 89 | 2 | MM14644 | |
| Pathway | PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY | 1.75e-03 | 38 | 89 | 3 | M229 | |
| Pathway | PID_SMAD2_3NUCLEAR_PATHWAY | 1.78e-03 | 82 | 89 | 4 | M2 | |
| Pathway | PID_REG_GR_PATHWAY | 1.78e-03 | 82 | 89 | 4 | M115 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 1.78e-03 | 82 | 89 | 4 | MM15394 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 1.89e-03 | 39 | 89 | 3 | M27238 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 1.95e-03 | 84 | 89 | 4 | M725 | |
| Pathway | PID_FOXM1_PATHWAY | 2.03e-03 | 40 | 89 | 3 | M176 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE | 2.09e-03 | 11 | 89 | 2 | M655 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION | 2.09e-03 | 11 | 89 | 2 | M27466 | |
| Pathway | REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS | 2.18e-03 | 41 | 89 | 3 | M29574 | |
| Pubmed | ARID4B MAP1A NUP58 LMO4 POM121C CREBBP MEF2C MEF2D GAB2 CEP350 ZNF106 JUN TOX4 LATS1 POM121 DST TRIM28 ARID2 | 5.48e-13 | 486 | 133 | 18 | 20936779 | |
| Pubmed | HSPG2 ZNF609 ESS2 AKAP8 ARID4B PATL1 LMO4 SRCAP POM121C CREBBP ZEB2 MEF2C MEF2D MYO5C JUN KMT2D DST KLF10 DCP1B ATXN2 NFATC3 TLE1 ARID2 MDC1 NCOA1 USP54 TBP | 5.24e-12 | 1429 | 133 | 27 | 35140242 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | ZNF609 ESS2 SPATA31E1 MAP1A POM121C ZNF804A LATS1 POM121 XIRP2 ATXN2 ARID2 MDC1 EIF4E PATJ CAMSAP1 UVRAG | 1.08e-11 | 430 | 133 | 16 | 35044719 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | STIM2 AKAP8 MPDZ MEF2D TMCC3 GAB2 CEP350 ZNF106 LATS1 DST DCP1B PIK3C2A NFATC3 PHF3 BRD4 USP54 PATJ CAMSAP1 CDC25B UVRAG | 1.19e-10 | 861 | 133 | 20 | 36931259 |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 2.04e-10 | 4 | 133 | 4 | 10469592 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | VWA5B2 HSPG2 PPRC1 KSR2 ZBTB4 GRID1 PLXND1 MED13L SRCAP POM121C ITPR2 PIKFYVE JUN KMT2D DST KLF10 TRIM28 BRD4 CAMSAP1 MMP14 UVRAG CD276 | 2.38e-10 | 1105 | 133 | 22 | 35748872 |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | ZNF609 AKAP8 NUP58 POM121C KHDC4 CREBBP MEF2D METTL13 KMT2D POM121 DCP1B PIK3C2A ATXN2 TLE1 AGFG2 | 2.82e-10 | 457 | 133 | 15 | 32344865 |
| Pubmed | ZNF609 NELFA MED13L CREBBP MEF2D JUN KMT2D PHF3 TLE1 BRD4 MDC1 NCOA1 | 5.75e-10 | 268 | 133 | 12 | 33640491 | |
| Pubmed | HSPG2 STIM2 ARHGAP9 LMO4 CREBBP ZEB2 EPG5 ZNF106 KMT2D TOX4 DST KLF10 DCP1B BRD4 PDE4DIP CAMSAP1 | 1.13e-09 | 591 | 133 | 16 | 15231748 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | AKAP8 ARID4B NELFA PATL1 GPRIN1 MEF2D USP19 LIG1 ZNF106 JUN KMT2D LATS1 BAZ2A TRIM28 PHF3 BRD4 MDC1 | 7.54e-09 | 774 | 133 | 17 | 15302935 |
| Pubmed | Interaction network of human early embryonic transcription factors. | ZNF609 ARID4B NUP58 LMO4 POM121C CREBBP ZEB2 KMT2D TLE1 ARID2 MDC1 NCOA1 | 1.19e-08 | 351 | 133 | 12 | 38297188 |
| Pubmed | ZNF609 ESS2 AKAP8 MPDZ PATL1 ITPR2 CEP350 PIKFYVE ZNF106 DCP1B PHF3 TLE1 MDC1 USP54 PATJ CAMSAP1 | 2.35e-08 | 733 | 133 | 16 | 34672954 | |
| Pubmed | MPDZ SRCAP GPRIN1 CREBBP KMT2D TOX4 LATS1 BAZ2A TRIM28 PHF3 ARID2 BRD4 MDC1 PATJ | 2.78e-08 | 549 | 133 | 14 | 38280479 | |
| Pubmed | Orai1 inhibitor STIM2β regulates myogenesis by controlling SOCE dependent transcriptional factors. | 5.47e-08 | 3 | 133 | 3 | 31346235 | |
| Pubmed | POM121 inhibits the macrophage inflammatory response by impacting NF-κB P65 nuclear accumulation. | 5.47e-08 | 3 | 133 | 3 | 30802453 | |
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 35507432 | ||
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 7.92e-08 | 94 | 133 | 7 | 21542922 | |
| Pubmed | 9.88e-08 | 12 | 133 | 4 | 14557543 | ||
| Pubmed | Two distinct human POM121 genes: requirement for the formation of nuclear pore complexes. | 2.18e-07 | 4 | 133 | 3 | 17900573 | |
| Pubmed | 2.18e-07 | 4 | 133 | 3 | 7983737 | ||
| Pubmed | 2.70e-07 | 15 | 133 | 4 | 10567404 | ||
| Pubmed | PDXDC1 SMAP1 ZNF609 MAP1A LRCH1 MEF2D LIG1 JUN DST PHF3 ARID2 CAMSAP1 | 2.96e-07 | 472 | 133 | 12 | 38943005 | |
| Pubmed | ZNF609 TOX LMO4 SRCAP MEF2D ZMAT3 JUN TOX4 KLF10 BAZ2A TRIM28 ARID2 BRD4 NCOA1 TBP | 5.22e-07 | 808 | 133 | 15 | 20412781 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 5.44e-07 | 5 | 133 | 3 | 12629516 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 5.88e-07 | 184 | 133 | 8 | 32908313 | |
| Pubmed | 1.08e-06 | 6 | 133 | 3 | 10497212 | ||
| Pubmed | 1.08e-06 | 6 | 133 | 3 | 12504854 | ||
| Pubmed | 1.08e-06 | 6 | 133 | 3 | 15063128 | ||
| Pubmed | 1.08e-06 | 6 | 133 | 3 | 18942147 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | AKAP8 SRCAP POM121C ITPR2 POM121 TRIM28 PHF3 ARID2 MDC1 USP54 CAMSAP1 | 1.11e-06 | 440 | 133 | 11 | 34244565 |
| Pubmed | ZNF609 ESS2 NELFA MED13L KHDC4 ZNF414 CREBBP ZEB2 MEF2D LIG1 JUN KMT2D ATXN2 ARID2 BRD4 EIF4E NCOA1 | 1.14e-06 | 1103 | 133 | 17 | 34189442 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | SMAP1 ZNF609 ESS2 MAP1A NELFA CREBBP MEF2D ZNF106 KLF10 TRIM28 PHF3 | 1.21e-06 | 444 | 133 | 11 | 34795231 |
| Pubmed | PPRC1 FOLH1 ZBTB4 NUP58 MED13L CMYA5 LMO4 CREBBP DSCAML1 ZEB2 CEP350 DST PDE4DIP OSBPL1A DGCR8 USP54 MTUS2 SH3BP5 | 2.09e-06 | 1285 | 133 | 18 | 35914814 | |
| Pubmed | 3.02e-06 | 8 | 133 | 3 | 16043483 | ||
| Pubmed | Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation. | 3.02e-06 | 8 | 133 | 3 | 16055710 | |
| Pubmed | STIM2 ZBTB4 POM121C KHDC4 CEP350 PIKFYVE METTL13 TOX4 POM121 ARID2 POM121B | 3.32e-06 | 493 | 133 | 11 | 15368895 | |
| Pubmed | 3.43e-06 | 233 | 133 | 8 | 37704626 | ||
| Pubmed | HSPG2 ZNF609 RBM42 ZNF804A CEP350 TOX4 POM121 ATXN2 PDE4DIP HSFX1 USP54 TBP | 4.11e-06 | 608 | 133 | 12 | 16713569 | |
| Pubmed | ZNF609 AKAP8 ARID4B MAP1A SRCAP POM121C CREBBP METTL13 BAZ2A TRIM28 ARID2 BRD4 TCF25 USP54 TAF4B TBP | 6.04e-06 | 1116 | 133 | 16 | 31753913 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 6.36e-06 | 180 | 133 | 7 | 35198878 | |
| Pubmed | PDXDC1 SMAP1 STIM2 ESS2 NELFA PATL1 GPRIN1 POM121C KHDC4 MEF2D JUN LATS1 POM121 PIK3C2A ATXN2 | 7.67e-06 | 1007 | 133 | 15 | 34597346 | |
| Pubmed | 8.64e-06 | 72 | 133 | 5 | 31248990 | ||
| Pubmed | 8.82e-06 | 11 | 133 | 3 | 10454579 | ||
| Pubmed | PDXDC1 SMAP1 STIM2 AKAP8 PLXND1 GPRIN1 USP19 GAB2 CEP350 LIG1 DST DGCR8 CAMSAP1 | 9.54e-06 | 777 | 133 | 13 | 35844135 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 1.16e-05 | 363 | 133 | 9 | 14691545 | |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 1.36e-05 | 38 | 133 | 4 | 12791264 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 1.39e-05 | 203 | 133 | 7 | 22083510 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 36590171 | ||
| Pubmed | A risk assessment model of acute liver allograft rejection by genetic polymorphism of CD276. | 1.45e-05 | 2 | 133 | 2 | 31044564 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 20141543 | ||
| Pubmed | Molecular Pathway to Protection From Age-Dependent Photoreceptor Degeneration in Mef2 Deficiency. | 1.45e-05 | 2 | 133 | 2 | 28738418 | |
| Pubmed | Mutations in SRCAP, encoding SNF2-related CREBBP activator protein, cause Floating-Harbor syndrome. | 1.45e-05 | 2 | 133 | 2 | 22265015 | |
| Pubmed | A ketogenic diet rescues hippocampal memory defects in a mouse model of Kabuki syndrome. | 1.45e-05 | 2 | 133 | 2 | 27999180 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 35776116 | ||
| Pubmed | PATJ and MPDZ are required for trophectoderm lineage specification in early mouse embryos. | 1.45e-05 | 2 | 133 | 2 | 37318097 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 36932261 | ||
| Pubmed | MEF2D and MEF2C pathways disruption in sporadic and familial ALS patients. | 1.45e-05 | 2 | 133 | 2 | 26921792 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 20353996 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 9060628 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 15328344 | ||
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 1.45e-05 | 2 | 133 | 2 | 9460924 | |
| Pubmed | Cell-type-selective induction of c-jun by TAF4b directs ovarian-specific transcription networks. | 1.45e-05 | 2 | 133 | 2 | 16473943 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 35339471 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 35017665 | ||
| Pubmed | Maintenance of spermatogenesis requires TAF4b, a gonad-specific subunit of TFIID. | 1.45e-05 | 2 | 133 | 2 | 15774719 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 19544488 | ||
| Pubmed | 1.45e-05 | 284 | 133 | 8 | 15057824 | ||
| Pubmed | TOX LMO4 CREBBP MEF2C MEF2D PIKFYVE JUN TOX4 BAZ2A TRIM28 BRD4 NCOA1 | 1.91e-05 | 709 | 133 | 12 | 22988430 | |
| Pubmed | 1.93e-05 | 14 | 133 | 3 | 12482968 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 2.40e-05 | 398 | 133 | 9 | 35016035 | |
| Pubmed | 2.41e-05 | 15 | 133 | 3 | 26184334 | ||
| Pubmed | 2.41e-05 | 15 | 133 | 3 | 15701600 | ||
| Pubmed | 2.41e-05 | 15 | 133 | 3 | 14697343 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | ESS2 AKAP8 ARID4B CREBBP ZEB2 MEF2C MEF2D JUN METTL13 KMT2D TLE1 CAMSAP1 TBP | 2.66e-05 | 857 | 133 | 13 | 25609649 |
| Pubmed | 2.69e-05 | 225 | 133 | 7 | 12168954 | ||
| Pubmed | 2.74e-05 | 152 | 133 | 6 | 38360978 | ||
| Pubmed | 2.86e-05 | 407 | 133 | 9 | 12693553 | ||
| Pubmed | 3.57e-05 | 17 | 133 | 3 | 27779093 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ZNF609 AKAP8 ARID4B RBM42 SRCAP POM121C ZNF106 JUN KMT2D TOX4 DST BAZ2A TRIM28 PHF3 BRD4 MDC1 | 3.69e-05 | 1294 | 133 | 16 | 30804502 |
| Pubmed | 4.28e-05 | 18 | 133 | 3 | 18664271 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 34463256 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 26707143 | ||
| Pubmed | An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133. | 4.34e-05 | 3 | 133 | 2 | 18093911 | |
| Pubmed | The cardiac pacemaker-specific channel Hcn4 is a direct transcriptional target of MEF2. | 4.34e-05 | 3 | 133 | 2 | 19477969 | |
| Pubmed | Relative contribution of SCA2, SCA3 and SCA17 in Korean patients with parkinsonism and ataxia. | 4.34e-05 | 3 | 133 | 2 | 21334959 | |
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 9971820 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 10848596 | ||
| Pubmed | In vivo analysis of MEF2 transcription factors in synapse regulation and neuronal survival. | 4.34e-05 | 3 | 133 | 2 | 22496871 | |
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 11713256 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 12403818 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 15225551 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 15743823 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 9642216 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 27989458 | ||
| Pubmed | Transcriptional activation by STAT6 requires the direct interaction with NCoA-1. | 4.34e-05 | 3 | 133 | 2 | 11574547 | |
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 12705904 | ||
| Pubmed | Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. | 4.34e-05 | 3 | 133 | 2 | 8028671 | |
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 21106530 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 18650384 | ||
| Pubmed | The MADS transcription factor Mef2c is a pivotal modulator of myeloid cell fate. | 4.34e-05 | 3 | 133 | 2 | 18326819 | |
| Interaction | TEAD1 interactions | ZNF609 ARID4B MPDZ CREBBP ZEB2 MEF2C MEF2D JUN KMT2D TLE1 ARID2 NCOA1 TBP | 6.51e-11 | 176 | 124 | 13 | int:TEAD1 |
| Interaction | NUP35 interactions | ZNF609 AKAP8 NUP58 POM121C KHDC4 CREBBP MEF2D KMT2D POM121 DCP1B PIK3C2A ATXN2 TRIM28 TLE1 AGFG2 | 5.40e-08 | 424 | 124 | 15 | int:NUP35 |
| Interaction | YWHAH interactions | STIM2 AKAP8 KSR2 MPDZ CREBBP MEF2D TMCC3 GAB2 CEP350 ZNF106 JUN LATS1 DST DCP1B PIK3C2A NFATC3 PHF3 BRD4 NCOA1 USP54 PATJ CAMSAP1 CDC25B UVRAG | 5.42e-08 | 1102 | 124 | 24 | int:YWHAH |
| Interaction | EGR2 interactions | ZNF609 ARID4B LMO4 CREBBP ZEB2 KMT2D TLE1 ARID2 PDE4DIP NCOA1 | 1.05e-07 | 171 | 124 | 10 | int:EGR2 |
| Interaction | AR interactions | MAGEA11 ZNF609 FOLH1 NELFA MED13L SRCAP CREBBP MEF2D MYO5C JUN METTL13 KMT2D TRIM28 PHF3 TLE1 ARID2 BRD4 MDC1 NCOA1 USP54 CDC25B TBP | 1.55e-07 | 992 | 124 | 22 | int:AR |
| Interaction | MYOD1 interactions | 3.42e-07 | 194 | 124 | 10 | int:MYOD1 | |
| Interaction | KLF5 interactions | 3.58e-07 | 195 | 124 | 10 | int:KLF5 | |
| Interaction | CRX interactions | SMAP1 ZNF609 ARID4B NRL LMO4 CREBBP ZEB2 KMT2D TLE1 ARID2 NCOA1 | 4.95e-07 | 254 | 124 | 11 | int:CRX |
| Interaction | TLE3 interactions | ZNF609 ESS2 AKAP8 ZBTB4 KHDC4 CREBBP KMT2D POM121 TLE1 ARID2 BRD4 AGFG2 NCOA1 | 5.72e-07 | 376 | 124 | 13 | int:TLE3 |
| Interaction | SOX7 interactions | 7.30e-07 | 82 | 124 | 7 | int:SOX7 | |
| Interaction | ETS1 interactions | 8.24e-07 | 121 | 124 | 8 | int:ETS1 | |
| Interaction | FHL3 interactions | RBM42 PATL1 LMO4 POM121C POM121 ATXN2 TRIM28 TMEM108 CDC25B MMP14 MTUS2 | 1.12e-06 | 276 | 124 | 11 | int:FHL3 |
| Interaction | SOX10 interactions | 1.60e-06 | 92 | 124 | 7 | int:SOX10 | |
| Interaction | FOXI1 interactions | 1.60e-06 | 92 | 124 | 7 | int:FOXI1 | |
| Interaction | SOX9 interactions | 2.29e-06 | 97 | 124 | 7 | int:SOX9 | |
| Interaction | HNF1B interactions | 2.72e-06 | 190 | 124 | 9 | int:HNF1B | |
| Interaction | TOP3B interactions | VWA5B2 HSPG2 PPRC1 KSR2 ZBTB4 GRID1 PATL1 PLXND1 MED13L SRCAP POM121C ITPR2 PIKFYVE JUN KMT2D DST KLF10 ATXN2 TRIM28 BRD4 MDC1 CAMSAP1 MMP14 UVRAG CD276 | 2.80e-06 | 1470 | 124 | 25 | int:TOP3B |
| Interaction | SP7 interactions | ZNF609 ESS2 AKAP8 ARID4B CREBBP ZEB2 MEF2D KMT2D TLE1 ARID2 NCOA1 | 2.86e-06 | 304 | 124 | 11 | int:SP7 |
| Interaction | SMG7 interactions | ZNF609 ESS2 PATL1 CREBBP MEF2D ZNF106 KMT2D LATS1 ATXN2 TLE1 NCOA1 | 4.54e-06 | 319 | 124 | 11 | int:SMG7 |
| Interaction | NXF1 interactions | ESS2 AKAP8 MAP1A NELFA WDR81 MPDZ MIEN1 NUP58 LMO4 POM121C KHDC4 MEF2D ITPR2 CEP350 ZNF106 JUN POM121 ATXN2 NFATC3 TRIM28 BRD4 MTUS2 SH3BP5 | 6.88e-06 | 1345 | 124 | 23 | int:NXF1 |
| Interaction | HNF4A interactions | 7.91e-06 | 275 | 124 | 10 | int:HNF4A | |
| Interaction | ERG interactions | 9.98e-06 | 223 | 124 | 9 | int:ERG | |
| Interaction | TLX1 interactions | 1.29e-05 | 175 | 124 | 8 | int:TLX1 | |
| Interaction | YWHAB interactions | STIM2 AKAP8 NELFA KSR2 TMCC3 GAB2 CEP350 ZNF106 LATS1 DST DCP1B PIK3C2A NFATC3 PHF3 TCF25 USP54 CAMSAP1 CDC25B UVRAG | 1.38e-05 | 1014 | 124 | 19 | int:YWHAB |
| Interaction | GSC interactions | 1.62e-05 | 87 | 124 | 6 | int:GSC | |
| Interaction | YWHAZ interactions | STIM2 AKAP8 NELFA KSR2 LRCH1 MEF2C TMCC3 GAB2 LATS1 DST DCP1B PIK3C2A NFATC3 PHF3 BRD4 MDC1 TCF25 USP54 CAMSAP1 CDC25B UVRAG GP1BA | 1.66e-05 | 1319 | 124 | 22 | int:YWHAZ |
| Interaction | CLDN1 interactions | 1.84e-05 | 26 | 124 | 4 | int:CLDN1 | |
| Interaction | LHX8 interactions | 1.84e-05 | 53 | 124 | 5 | int:LHX8 | |
| Interaction | YWHAG interactions | STIM2 AKAP8 KSR2 MPDZ MEF2D TMCC3 GAB2 CEP350 ZNF106 LATS1 DST DCP1B PIK3C2A NFATC3 PHF3 TCF25 USP54 PATJ CAMSAP1 CDC25B UVRAG | 2.33e-05 | 1248 | 124 | 21 | int:YWHAG |
| Interaction | ASF1A interactions | 2.40e-05 | 249 | 124 | 9 | int:ASF1A | |
| Interaction | CRYL1 interactions | 2.42e-05 | 56 | 124 | 5 | int:CRYL1 | |
| Interaction | QRICH1 interactions | 2.57e-05 | 140 | 124 | 7 | int:QRICH1 | |
| Interaction | SMARCC1 interactions | ARID4B SRCAP CREBBP JUN METTL13 LATS1 TRIM28 ARID2 BRD4 MDC1 NCOA1 | 2.57e-05 | 384 | 124 | 11 | int:SMARCC1 |
| Interaction | SOX17 interactions | 2.67e-05 | 95 | 124 | 6 | int:SOX17 | |
| Interaction | GATA2 interactions | 3.25e-05 | 199 | 124 | 8 | int:GATA2 | |
| Interaction | TERF2IP interactions | ZNF609 ESS2 NELFA SRCAP ZNF414 CREBBP MEF2D BAZ2A TRIM28 PHF3 BRD4 MDC1 DGCR8 | 3.63e-05 | 552 | 124 | 13 | int:TERF2IP |
| Interaction | KLF8 interactions | ZNF609 AKAP8 ARID4B POM121C CREBBP ZEB2 MEF2D KMT2D ARID2 DGCR8 | 3.70e-05 | 329 | 124 | 10 | int:KLF8 |
| Interaction | SMAD9 interactions | 4.54e-05 | 153 | 124 | 7 | int:SMAD9 | |
| Interaction | NFIC interactions | 4.76e-05 | 210 | 124 | 8 | int:NFIC | |
| Interaction | CCDC60 interactions | 4.80e-05 | 12 | 124 | 3 | int:CCDC60 | |
| Interaction | PML interactions | SMAP1 ZNF609 ESS2 MAP1A NELFA PATL1 CREBBP MEF2D ITPR2 ZNF106 JUN KLF10 TRIM28 PHF3 BRD4 MDC1 EIF4E | 5.81e-05 | 933 | 124 | 17 | int:PML |
| Interaction | WWTR1 interactions | MPDZ SRCAP GPRIN1 CREBBP KMT2D TOX4 LATS1 PHF3 ARID2 BRD4 PATJ | 6.05e-05 | 422 | 124 | 11 | int:WWTR1 |
| Interaction | EN1 interactions | 6.11e-05 | 110 | 124 | 6 | int:EN1 | |
| Interaction | GCM1 interactions | 6.22e-05 | 68 | 124 | 5 | int:GCM1 | |
| Interaction | PAX8 interactions | 6.42e-05 | 111 | 124 | 6 | int:PAX8 | |
| Interaction | ETV4 interactions | 6.67e-05 | 69 | 124 | 5 | int:ETV4 | |
| Interaction | HOXB2 interactions | 6.91e-05 | 36 | 124 | 4 | int:HOXB2 | |
| Interaction | TBR1 interactions | 7.10e-05 | 113 | 124 | 6 | int:TBR1 | |
| Interaction | TBXT interactions | 8.21e-05 | 116 | 124 | 6 | int:TBXT | |
| Interaction | NFIX interactions | 8.22e-05 | 227 | 124 | 8 | int:NFIX | |
| Interaction | CREBBP interactions | SRCAP CREBBP EPG5 ZNF106 JUN KMT2D LATS1 TRIM28 BRD4 MDC1 NCOA1 CDC25B TBP | 8.33e-05 | 599 | 124 | 13 | int:CREBBP |
| Interaction | STAT4 interactions | 8.57e-05 | 38 | 124 | 4 | int:STAT4 | |
| Interaction | PAX6 interactions | 9.00e-05 | 366 | 124 | 10 | int:PAX6 | |
| Interaction | MAPRE3 interactions | 9.01e-05 | 230 | 124 | 8 | int:MAPRE3 | |
| Interaction | GATA1 interactions | 9.16e-05 | 171 | 124 | 7 | int:GATA1 | |
| Interaction | SYNE3 interactions | STIM2 NUP58 POM121C TMCC3 CEP350 LATS1 DST DCP1B PIK3C2A USP54 CAMSAP1 | 9.51e-05 | 444 | 124 | 11 | int:SYNE3 |
| Interaction | F12 interactions | 1.13e-04 | 77 | 124 | 5 | int:F12 | |
| Interaction | PAX7 interactions | 1.19e-04 | 124 | 124 | 6 | int:PAX7 | |
| Interaction | RUNX2 interactions | 1.30e-04 | 126 | 124 | 6 | int:RUNX2 | |
| Interaction | SIRT6 interactions | AKAP8 SRCAP POM121C CREBBP ITPR2 POM121 TRIM28 PHF3 ARID2 BRD4 MDC1 USP54 CAMSAP1 | 1.33e-04 | 628 | 124 | 13 | int:SIRT6 |
| Interaction | MAPK1 interactions | NRL KSR2 ARHGAP9 CREBBP GAB2 CEP350 JUN PHF3 BRD4 NCOA1 DGCR8 HSF4 | 1.34e-04 | 543 | 124 | 12 | int:MAPK1 |
| Interaction | FOS interactions | 1.36e-04 | 312 | 124 | 9 | int:FOS | |
| Interaction | LHX2 interactions | 1.40e-04 | 183 | 124 | 7 | int:LHX2 | |
| Interaction | MARF1 interactions | 1.41e-04 | 128 | 124 | 6 | int:MARF1 | |
| Interaction | HDAC1 interactions | ZNF609 ARID4B FOLH1 LMO4 CREBBP ZEB2 MEF2D USP19 JUN KMT2D TOX4 DST BAZ2A TRIM28 TLE1 BRD4 CAMSAP1 TBP | 1.49e-04 | 1108 | 124 | 18 | int:HDAC1 |
| Interaction | LHX3 interactions | 1.50e-04 | 185 | 124 | 7 | int:LHX3 | |
| Interaction | ZMYND12 interactions | 1.52e-04 | 82 | 124 | 5 | int:ZMYND12 | |
| Interaction | SNRNP40 interactions | HSPG2 ZNF609 ESS2 AKAP8 ZBTB4 RBM42 POM121C KHDC4 POM121 BAZ2A ARID2 BRD4 MDC1 | 1.53e-04 | 637 | 124 | 13 | int:SNRNP40 |
| Interaction | MYBPC2 interactions | 1.67e-04 | 45 | 124 | 4 | int:MYBPC2 | |
| Interaction | IRF4 interactions | 1.80e-04 | 85 | 124 | 5 | int:IRF4 | |
| Interaction | DTX2 interactions | 2.07e-04 | 330 | 124 | 9 | int:DTX2 | |
| Interaction | NCOA2 interactions | 2.39e-04 | 141 | 124 | 6 | int:NCOA2 | |
| Interaction | GTF2B interactions | 2.39e-04 | 141 | 124 | 6 | int:GTF2B | |
| Interaction | SPIB interactions | 2.40e-04 | 20 | 124 | 3 | int:SPIB | |
| Interaction | CSNK2A1 interactions | MAGEA11 AKAP8 ARID4B CREBBP ZEB2 MEF2C LIG1 JUN DST DCP1B ATXN2 TRIM28 BRD4 MDC1 USP54 CDC25B | 2.57e-04 | 956 | 124 | 16 | int:CSNK2A1 |
| Interaction | FEV interactions | 2.64e-04 | 203 | 124 | 7 | int:FEV | |
| Interaction | SMARCD1 interactions | 3.13e-04 | 349 | 124 | 9 | int:SMARCD1 | |
| Interaction | SMARCC2 interactions | 3.40e-04 | 353 | 124 | 9 | int:SMARCC2 | |
| Interaction | SFN interactions | MAP1A TMCC3 GAB2 CEP350 LATS1 DST PIK3C2A NFATC3 TRIM28 PHF3 USP54 CAMSAP1 CDC25B | 3.42e-04 | 692 | 124 | 13 | int:SFN |
| Interaction | RNF168 interactions | 3.50e-04 | 98 | 124 | 5 | int:RNF168 | |
| Interaction | YAP1 interactions | ESS2 MPDZ SRCAP CREBBP JUN KMT2D TOX4 LATS1 BAZ2A TRIM28 PHF3 ARID2 BRD4 MDC1 DGCR8 PATJ UVRAG | 3.91e-04 | 1095 | 124 | 17 | int:YAP1 |
| Interaction | BCL3 interactions | 3.92e-04 | 56 | 124 | 4 | int:BCL3 | |
| Interaction | TPRX2 interactions | 3.92e-04 | 56 | 124 | 4 | int:TPRX2 | |
| Interaction | H3C1 interactions | ARID4B SRCAP GPRIN1 CREBBP PIKFYVE KMT2D XIRP2 BAZ2A TRIM28 PHF3 ARID2 BRD4 MDC1 CAMSAP1 TBP | 4.29e-04 | 901 | 124 | 15 | int:H3C1 |
| Interaction | IRF8 interactions | 4.48e-04 | 58 | 124 | 4 | int:IRF8 | |
| Interaction | LOXL4 interactions | 4.60e-04 | 104 | 124 | 5 | int:LOXL4 | |
| Interaction | NCOA3 interactions | 4.78e-04 | 224 | 124 | 7 | int:NCOA3 | |
| Interaction | YWHAQ interactions | KSR2 MEF2D TMCC3 GAB2 CEP350 ZNF106 LATS1 DST PIK3C2A NFATC3 TRIM28 BRD4 NCOA1 USP54 CAMSAP1 CDC25B UVRAG | 4.96e-04 | 1118 | 124 | 17 | int:YWHAQ |
| Interaction | KLF3 interactions | 5.31e-04 | 228 | 124 | 7 | int:KLF3 | |
| Interaction | LHX4 interactions | 5.72e-04 | 166 | 124 | 6 | int:LHX4 | |
| Interaction | SIN3A interactions | 5.79e-04 | 380 | 124 | 9 | int:SIN3A | |
| Interaction | GOLGA2 interactions | PDXDC1 ZNF609 ARID4B ZBTB4 MPDZ PATL1 LMO4 ZNF414 KMT2D LATS1 POM121 TLE1 TBP | 5.88e-04 | 733 | 124 | 13 | int:GOLGA2 |
| Interaction | SOWAHA interactions | 5.97e-04 | 27 | 124 | 3 | int:SOWAHA | |
| Interaction | ANAPC2 interactions | 6.20e-04 | 234 | 124 | 7 | int:ANAPC2 | |
| Interaction | PPARG interactions | 6.33e-04 | 307 | 124 | 8 | int:PPARG | |
| Interaction | POLR2E interactions | 6.46e-04 | 308 | 124 | 8 | int:POLR2E | |
| Interaction | YWHAE interactions | STIM2 AKAP8 KSR2 LRCH1 TMCC3 GAB2 ZNF106 LATS1 DST DCP1B PIK3C2A TRIM28 BRD4 TCF25 USP54 CAMSAP1 CDC25B UVRAG | 6.73e-04 | 1256 | 124 | 18 | int:YWHAE |
| Interaction | APC interactions | 6.84e-04 | 389 | 124 | 9 | int:APC | |
| Interaction | VSX1 interactions | 7.33e-04 | 66 | 124 | 4 | int:VSX1 | |
| Interaction | NUP155 interactions | PDXDC1 STIM2 NUP58 POM121C TMCC3 ITPR2 KMT2D POM121 PIK3C2A BRD4 | 7.40e-04 | 477 | 124 | 10 | int:NUP155 |
| GeneFamily | Myocyte enhancer factor 2 proteins|MADS box family | 1.12e-04 | 4 | 79 | 2 | 649 | |
| GeneFamily | Myocyte enhancer factor 2 proteins|MADS box family | 1.87e-04 | 5 | 79 | 2 | 1086 | |
| GeneFamily | PHD finger proteins | 6.49e-04 | 90 | 79 | 4 | 88 | |
| GeneFamily | PDZ domain containing|Crumbs complex | 6.65e-04 | 9 | 79 | 2 | 1223 | |
| GeneFamily | AT-rich interaction domain containing | 1.91e-03 | 15 | 79 | 2 | 418 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.46e-03 | 17 | 79 | 2 | 486 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | MED13L ZNF804A CREBBP CEP350 PIKFYVE JUN DST KLF10 ATXN2 PHF3 TLE1 EIF4E NCOA1 UVRAG | 5.83e-08 | 466 | 126 | 14 | M13522 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | MED13L ZNF804A CREBBP ZEB2 CEP350 PIKFYVE JUN DST KLF10 PIK3C2A ATXN2 NFATC3 PHF3 TLE1 EIF4E NCOA1 UVRAG | 7.71e-07 | 856 | 126 | 17 | M4500 |
| Coexpression | GSE32986_GMCSF_AND_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN | 5.60e-06 | 199 | 126 | 8 | M8622 | |
| Coexpression | GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_DN | 5.81e-06 | 200 | 126 | 8 | M4667 | |
| Coexpression | GSE27786_BCELL_VS_ERYTHROBLAST_UP | 5.81e-06 | 200 | 126 | 8 | M4810 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 7.75e-06 | 208 | 126 | 8 | MM581 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | STIM2 ZNF609 ARID4B TOX ZBTB4 ARHGAP9 CREBBP ZEB2 MEF2D EPG5 ITPR2 CEP350 PIKFYVE ZMAT3 KMT2D LATS1 NFATC3 PHF3 ARID2 PDE4DIP NCOA1 | 8.65e-06 | 1492 | 126 | 21 | M40023 |
| Coexpression | GAUTAM_EYE_CORNEA_ELF3_HIGH_EPITHELIAL_CELLS | 9.11e-06 | 152 | 126 | 7 | M43614 | |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 1.03e-05 | 155 | 126 | 7 | M39246 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | 1.13e-05 | 219 | 126 | 8 | M41199 | |
| Coexpression | GSE13547_WT_VS_ZFX_KO_BCELL_UP | 1.44e-05 | 163 | 126 | 7 | M2997 | |
| Coexpression | LINDGREN_BLADDER_CANCER_CLUSTER_1_DN | PDXDC1 MAGEA11 ATG9B COL15A1 MAP1A PATL1 TCF25 TMEM108 CDC25B SH3BP5 | 1.51e-05 | 378 | 126 | 10 | M17788 |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | PDXDC1 ESS2 AKAP8 PATL1 POM121C TMCC3 POM121 PIK3C2A BAZ2A PHF3 EIF4E PDXDC2P NCOA1 | 2.50e-05 | 680 | 126 | 13 | M41089 |
| Coexpression | CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE | 3.68e-05 | 39 | 126 | 4 | M427 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | ARID4B NUP58 MED13L CREBBP ZEB2 MEF2D DST KLF10 BAZ2A PHF3 TLE1 BRD4 PDE4DIP NCOA1 | 4.27e-05 | 822 | 126 | 14 | M6782 |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | ARID4B LMO4 USP19 PGM5 ZNF106 ATXN2 NFATC3 DGCR8 MMP14 MTUS2 SH3BP5 | 4.32e-05 | 519 | 126 | 11 | M3395 |
| Coexpression | CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE | 4.95e-05 | 42 | 126 | 4 | MM617 | |
| Coexpression | GSE360_DC_VS_MAC_L_MAJOR_DN | 5.15e-05 | 199 | 126 | 7 | M5182 | |
| Coexpression | GSE14308_TH1_VS_NAIVE_CD4_TCELL_DN | 5.32e-05 | 200 | 126 | 7 | M3377 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | ARID4B LMO4 USP19 PGM5 ZNF106 ATXN2 NFATC3 DGCR8 MMP14 MTUS2 SH3BP5 | 6.48e-05 | 543 | 126 | 11 | MM997 |
| Coexpression | ZHONG_PFC_MAJOR_TYPES_INTERNEURON | 8.40e-05 | 18 | 126 | 3 | M39076 | |
| Coexpression | GSE40274_CTRL_VS_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 8.90e-05 | 150 | 126 | 6 | M9139 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 1.05e-04 | 300 | 126 | 8 | M8702 | |
| Coexpression | MCCLUNG_CREB1_TARGETS_UP | 1.24e-04 | 100 | 126 | 5 | M6920 | |
| Coexpression | MCCLUNG_CREB1_TARGETS_UP | 1.36e-04 | 102 | 126 | 5 | MM680 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | NELFA ZBTB4 MED13L ZEB2 TMCC3 JUN TOX4 LATS1 ATXN2 RBMS3 ARID2 USP54 PATJ | 1.41e-04 | 807 | 126 | 13 | M16651 |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_ZFX_KO_BCELL_UP | 1.60e-04 | 167 | 126 | 6 | M2995 | |
| Coexpression | GSE3565_CTRL_VS_LPS_INJECTED_DUSP1_KO_SPLENOCYTES_DN | 1.82e-04 | 171 | 126 | 6 | M6321 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 2.20e-04 | 177 | 126 | 6 | M39245 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 2.40e-04 | 180 | 126 | 6 | M8239 | |
| Coexpression | GSE18893_TCONV_VS_TREG_2H_TNF_STIM_DN | 3.59e-04 | 194 | 126 | 6 | M7306 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_T_ALPHA_BETA_ENTRY_CELL | 3.65e-04 | 70 | 126 | 4 | M45777 | |
| Coexpression | GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_DN | 3.69e-04 | 195 | 126 | 6 | M7310 | |
| Coexpression | GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_UP | 3.90e-04 | 197 | 126 | 6 | M3343 | |
| Coexpression | GSE28130_ACTIVATED_VS_INDUCEED_TREG_UP | 3.90e-04 | 197 | 126 | 6 | M8343 | |
| Coexpression | GSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_UP | 4.00e-04 | 198 | 126 | 6 | M7200 | |
| Coexpression | GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_UP | 4.11e-04 | 199 | 126 | 6 | M9420 | |
| Coexpression | GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP | 4.11e-04 | 199 | 126 | 6 | M8381 | |
| Coexpression | GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_DN | 4.11e-04 | 199 | 126 | 6 | M3583 | |
| Coexpression | GSE19888_CTRL_VS_A3R_ACTIVATION_MAST_CELL_UP | 4.11e-04 | 199 | 126 | 6 | M7325 | |
| Coexpression | GSE40655_FOXO1_KO_VS_WT_NTREG_UP | 4.22e-04 | 200 | 126 | 6 | M9439 | |
| Coexpression | GSE14308_TH1_VS_INDUCED_TREG_DN | 4.22e-04 | 200 | 126 | 6 | M3379 | |
| Coexpression | GSE8685_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_DN | 4.22e-04 | 200 | 126 | 6 | M327 | |
| Coexpression | GSE27786_NKCELL_VS_MONO_MAC_UP | 4.22e-04 | 200 | 126 | 6 | M4860 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_72H_CD8_T_CELL_UP | 4.22e-04 | 200 | 126 | 6 | M3648 | |
| Coexpression | GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP | 4.22e-04 | 200 | 126 | 6 | M6027 | |
| Coexpression | GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_DN | 4.22e-04 | 200 | 126 | 6 | M5078 | |
| Coexpression | GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_LPS_STIM_DN | 4.22e-04 | 200 | 126 | 6 | M6354 | |
| Coexpression | GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_DN | 4.22e-04 | 200 | 126 | 6 | M2936 | |
| Coexpression | GSE7548_NAIVE_VS_DAY7_PCC_IMMUNIZATION_CD4_TCELL_UP | 4.22e-04 | 200 | 126 | 6 | M6836 | |
| Coexpression | GSE38304_MYC_NEG_VS_POS_GC_BCELL_UP | 4.22e-04 | 200 | 126 | 6 | M9273 | |
| Coexpression | GSE36078_WT_VS_IL1R_KO_LUNG_DC_UP | 4.22e-04 | 200 | 126 | 6 | M9299 | |
| Coexpression | GSE20715_WT_VS_TLR4_KO_6H_OZONE_LUNG_UP | 4.22e-04 | 200 | 126 | 6 | M4351 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_EPITHELIAL_CELL_AGEING | SMAP1 ZNF609 AKAP8 CDHR5 MED13L LMO4 CEP350 NFATC3 TRIM28 NCOA1 | 4.30e-04 | 568 | 126 | 10 | MM3824 |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 5.95e-08 | 184 | 127 | 8 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.62e-08 | 190 | 127 | 8 | 96a92212ea3fb35fa3d0da495e504edc61c71c23 | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.37e-07 | 182 | 127 | 7 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-06 | 184 | 127 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.08e-06 | 186 | 127 | 7 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 1.44e-06 | 194 | 127 | 7 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-06 | 196 | 127 | 7 | 22767bcf0095d9eb0cbed7cdc74e4d32d9357e1b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-06 | 196 | 127 | 7 | adee900dcd16dbaba15c58bdcace09ba20214950 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Vein|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.76e-06 | 200 | 127 | 7 | 7eb366b2c5394af7c77650bde6261e7dac67154e | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 8.82e-06 | 168 | 127 | 6 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.12e-06 | 169 | 127 | 6 | f086b50791e1c93e253eb5e8d6c4bf617b1416c3 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.76e-06 | 171 | 127 | 6 | ea60d9e9df28ab991fbdb596784b44f6a9fc5827 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 176 | 127 | 6 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.27e-05 | 179 | 127 | 6 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.27e-05 | 179 | 127 | 6 | a28a1de500a74c6dcc43481abf9ec0f7e7a300a9 | |
| ToppCell | COVID-19_Severe-Hematopoietic_SC-HSPC|COVID-19_Severe / Disease group, lineage and cell class | 1.43e-05 | 183 | 127 | 6 | 4146b1c0e5f76d25226745abfa28f77127a444fc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-05 | 183 | 127 | 6 | dc19857b66dcadbf7c87de91f7b1f4e8ef2857ed | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 183 | 127 | 6 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-05 | 183 | 127 | 6 | 4759560e5b4f4e5a00e5f933e3451a27c7c4aefe | |
| ToppCell | COVID-19_Severe-Hematopoietic_SC|COVID-19_Severe / Disease group, lineage and cell class | 1.43e-05 | 183 | 127 | 6 | 92aab7ce65aca17988bc2add4ff9fb8384e2c21b | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 183 | 127 | 6 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-05 | 184 | 127 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-05 | 184 | 127 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-05 | 184 | 127 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-05 | 185 | 127 | 6 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 1.53e-05 | 185 | 127 | 6 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-05 | 185 | 127 | 6 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.57e-05 | 186 | 127 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.57e-05 | 186 | 127 | 6 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.57e-05 | 186 | 127 | 6 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-05 | 188 | 127 | 6 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 1.72e-05 | 189 | 127 | 6 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 1.72e-05 | 189 | 127 | 6 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.77e-05 | 190 | 127 | 6 | 0db545a4cba7534bad2693e0d565cde7dbc7a586 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.77e-05 | 190 | 127 | 6 | 0724665ac8238f2383c3a929d89abf4a48ec2420 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 1.83e-05 | 191 | 127 | 6 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.88e-05 | 192 | 127 | 6 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 1.94e-05 | 193 | 127 | 6 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.94e-05 | 193 | 127 | 6 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.94e-05 | 193 | 127 | 6 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B-Naive_B_cells|lymph-node_spleen / Manually curated celltypes from each tissue | 1.99e-05 | 194 | 127 | 6 | 20967afbadb3cf80ba9f4d7ebda4e64389252e70 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.99e-05 | 194 | 127 | 6 | 87604c93d20f9171e0a1279bdb6ad73fe5fed356 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.05e-05 | 195 | 127 | 6 | 481989d2e5bd2582da3d86b0155c4d6615317067 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.05e-05 | 195 | 127 | 6 | 6108a27523d1b93a7fbe35cb95704a5ad9071e3c | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.05e-05 | 195 | 127 | 6 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+VCAM1+EC|kidney / Disease (COVID-19 only), tissue and cell type | 2.11e-05 | 196 | 127 | 6 | ac2c4a325efa8497a755cd31fb6a9d94d8e3bf42 | |
| ToppCell | COVID-19_Severe-PLT_4|World / Disease Group and Platelet Clusters | 2.11e-05 | 196 | 127 | 6 | ad43efdd4d73b6615f65f06a315b33576e317473 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.17e-05 | 197 | 127 | 6 | b597c292fc1cb381a4325fed15a32966c38def28 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.17e-05 | 197 | 127 | 6 | 82b8e22317cad6d3786bd70d91107007c0ccd7cd | |
| ToppCell | Control-Lymphoid-Plasma,_B_cells|Lymphoid / Condition, Lineage and Cell class | 2.24e-05 | 198 | 127 | 6 | d2b7dd7919019dbfa18cfa52e64f4d27e56b9df6 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.24e-05 | 198 | 127 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-cortical_neurons_1|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 2.24e-05 | 198 | 127 | 6 | d81f35c0066558ff96dd06f58fca72cd82e681e8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-05 | 198 | 127 | 6 | 0a172c6d997c7cfbad34b56e80121bd104dee67d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-05 | 199 | 127 | 6 | 8b62d43af8b2ebb4c1b2d068d50beaf35728dbe7 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-05 | 199 | 127 | 6 | da5a88749d859d535daa030d0974485906cc0ba7 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M|organoid_Kanton_Nature / Sample Type, Dataset, Time_group, and Cell type. | 2.30e-05 | 199 | 127 | 6 | b2d7dea11207cca63d688f8051143850b29dbdf0 | |
| ToppCell | 10x5'v1-week_14-16-Endothelial-stroma-tip_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.37e-05 | 200 | 127 | 6 | 77ac1aa73c16a4f595ff01c6b4e171e0b8fed1e6 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-05 | 200 | 127 | 6 | b1be27d134a8633e3e7862c6a0d7be2001d387f0 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.37e-05 | 200 | 127 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-05 | 200 | 127 | 6 | dba96cda5f3b780a3d4171b61bc8aaddc1f5d466 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-05 | 200 | 127 | 6 | ced14d83222dbebca85c40540e76824e683354f3 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-05 | 200 | 127 | 6 | 7a69ad5b6c84f1aebacea5cacb9bc5c63dfd1dac | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal-GABAergic_neurons|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 2.37e-05 | 200 | 127 | 6 | c6bbd33bca86ac7a76a7ba704b3e141237d04549 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Whrn_Tox2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.63e-05 | 143 | 127 | 5 | 36ce6f163fb33141c86288086c354b91853fad25 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo1_Itga4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.82e-05 | 144 | 127 | 5 | 7de962346ba9653d90dd13bb7d977fe44d200bba | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo1_Itga4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.25e-05 | 155 | 127 | 5 | cba6f3f7742b4d5d54ad0a0ac0dd4016e73fe658 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.25e-05 | 155 | 127 | 5 | 8fdda4e3657ac56188ae88ed3caf145f4d9d1567 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-neuro-epithelial-EECs|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-04 | 162 | 127 | 5 | 478cf560ef33c5c324142c76417447d4a571a2c9 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.04e-04 | 163 | 127 | 5 | 6bed27d2f67a430a847da5eb47878d14b4949c45 | |
| ToppCell | BAL-Mild-cDC_11|Mild / Compartment, Disease Groups and Clusters | 1.08e-04 | 164 | 127 | 5 | 4bd9629d054545d1e3f9e5c127b5ac2388637106 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-Mast|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.14e-04 | 166 | 127 | 5 | 004ab6a1425d812c7ce572205875fd702d4a9659 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-04 | 168 | 127 | 5 | 37249f38f8f04ec5743097259de67b106ca2b02f | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-OPC_related|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.24e-04 | 169 | 127 | 5 | 29db25e7c5f31d98a08a35d7ec5ade203242bc50 | |
| ToppCell | Control-Mast_cells|Control / group, cell type (main and fine annotations) | 1.24e-04 | 169 | 127 | 5 | fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-OPC_related-Oligodendrocyte/OPC|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.24e-04 | 169 | 127 | 5 | b1611e61f635f8f9b87250e026ad30999cbee041 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.24e-04 | 169 | 127 | 5 | 78eb70dd916724e476eabccf18fb7fcec4210308 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.27e-04 | 170 | 127 | 5 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.27e-04 | 170 | 127 | 5 | a6fa0cab1fa829ec601fe48306b4c43c83425b04 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.27e-04 | 170 | 127 | 5 | b40255eee45eb18b5a297336d7f3845fd8f8aa3b | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 170 | 127 | 5 | 17bd7fd25a2657cb536ad47e294332920f759e95 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 1.27e-04 | 170 | 127 | 5 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | Control-Mast_cells-Mast_cells|Control / group, cell type (main and fine annotations) | 1.27e-04 | 170 | 127 | 5 | c80f6d29096c372da95a8407f402349ff1bb7018 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.31e-04 | 171 | 127 | 5 | 5efd15300f865ebf651e0888265cbd717bc3b9d3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.31e-04 | 171 | 127 | 5 | a2938e56cb5749004317798dc7ac0f0c2d4d8ae0 | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 173 | 127 | 5 | 25d72fa7a84baf5660ead6da67327590f5c91860 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 173 | 127 | 5 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.38e-04 | 173 | 127 | 5 | 7e3897868dd3f6e4974f593c60649a543ffc8693 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.38e-04 | 173 | 127 | 5 | d56e337eae727a29cd53cfd628e1b3c0a98e1f51 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 173 | 127 | 5 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | COVID-19-Myeloid-MoAM5,_CCL3L1|COVID-19 / Condition, Lineage and Cell class | 1.38e-04 | 173 | 127 | 5 | 502f888b7684ed39f5c577eedcacf673ae81d39e | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 173 | 127 | 5 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.50e-04 | 176 | 127 | 5 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | COVID-19-Myeloid-MoAM4|COVID-19 / Condition, Lineage and Cell class | 1.54e-04 | 177 | 127 | 5 | ca5d0c3d5c700bbe4c2da068eb02be6229afb9a0 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.54e-04 | 177 | 127 | 5 | 68f1139fc378f351e3b9e9f392aacb150025bf03 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.54e-04 | 177 | 127 | 5 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-04 | 177 | 127 | 5 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-HSC/MPP_and_pro-MEP|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.58e-04 | 178 | 127 | 5 | b8c301d65c0f37941e8e9414d55e90edb6ecc195 | |
| ToppCell | COVID-19-Myeloid-MoAM4|Myeloid / Condition, Lineage and Cell class | 1.58e-04 | 178 | 127 | 5 | fe0017e6a1f23dc45f644b9acacc7e8aa80d0116 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-04 | 180 | 127 | 5 | 6ac62bf1251978c8c12e715f7b73144fca619794 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-B_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.70e-04 | 181 | 127 | 5 | 477c572c5c1efceee49732cc9e8b1dad68a7e6e5 | |
| Computational | Genes in the cancer module 257. | 8.65e-05 | 156 | 73 | 7 | MODULE_257 | |
| Disease | breast carcinoma (is_marker_for) | 7.20e-06 | 66 | 119 | 5 | DOID:3459 (is_marker_for) | |
| Disease | retinal vasculature measurement | HSPG2 ARHGAP9 MED13L LRCH1 DSCAML1 MEF2C ZNF106 XIRP2 ATXN2 AGFG2 PATJ | 8.25e-06 | 517 | 119 | 11 | EFO_0010554 |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.64e-05 | 152 | 119 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Hydrocephalus | 4.83e-05 | 3 | 119 | 2 | cv:C0020255 | |
| Disease | Congenital hydrocephalus | 4.83e-05 | 3 | 119 | 2 | cv:C0020256 | |
| Disease | diet measurement | PDXDC1 TOX POM121L2 GRID1 KHDC4 MEF2C TMCC3 GAB2 NRXN3 DST ARID2 EIF4E TMEM108 SH3BP5 | 8.71e-05 | 1049 | 119 | 14 | EFO_0008111 |
| Disease | systemic lupus erythematosus | KSR2 MIEN1 ARHGAP9 CDHR5 SRCAP POM121C ZNF804A RAB44 PXK MYO5C TOX4 ATXN2 | 9.62e-05 | 799 | 119 | 12 | MONDO_0007915 |
| Disease | VELOCARDIOFACIAL SYNDROME | 1.60e-04 | 5 | 119 | 2 | 192430 | |
| Disease | Velocardiofacial syndrome | 1.60e-04 | 5 | 119 | 2 | cv:C0220704 | |
| Disease | Prostatic Neoplasms | COL15A1 FOLH1 CREBBP KMT2D BAZ2A ARID2 BRD4 NCOA1 PATJ CD276 | 2.03e-04 | 616 | 119 | 10 | C0033578 |
| Disease | Malignant neoplasm of prostate | COL15A1 FOLH1 CREBBP KMT2D BAZ2A ARID2 BRD4 NCOA1 PATJ CD276 | 2.03e-04 | 616 | 119 | 10 | C0376358 |
| Disease | wellbeing measurement, alcohol consumption measurement | 2.33e-04 | 74 | 119 | 4 | EFO_0007869, EFO_0007878 | |
| Disease | hydrocephalus (is_implicated_in) | 2.39e-04 | 6 | 119 | 2 | DOID:10908 (is_implicated_in) | |
| Disease | Schizophrenia | ESS2 FOLH1 GRID1 CMYA5 ZNF804A SLC1A6 JUN NRXN3 ATXN2 ERVK-8 DGCR8 TBP | 2.42e-04 | 883 | 119 | 12 | C0036341 |
| Disease | stroke | 3.02e-04 | 144 | 119 | 5 | EFO_0000712 | |
| Disease | migraine disorder | 6.29e-04 | 357 | 119 | 7 | MONDO_0005277 | |
| Disease | Parkinson disease, late-onset | 7.11e-04 | 10 | 119 | 2 | cv:C3160718 | |
| Disease | platelet glycoprotein ib alpha chain measurement | 7.11e-04 | 10 | 119 | 2 | EFO_0020645 | |
| Disease | PARKINSON DISEASE, LATE-ONSET | 7.11e-04 | 10 | 119 | 2 | 168600 | |
| Disease | late onset Parkinson's disease (is_implicated_in) | 8.66e-04 | 11 | 119 | 2 | DOID:0060892 (is_implicated_in) | |
| Disease | red blood cell density measurement | PDXDC1 ZEB2 MEF2C PXK ZNF106 DST ATXN2 RBMS3 ARID2 BRD4 TAF4B | 8.83e-04 | 880 | 119 | 11 | EFO_0007978 |
| Disease | chronotype measurement | TOX ARHGAP9 MED13L ZNF804A MEF2C KMT2D NRXN3 NFATC3 ARID2 TMEM108 PATJ | 8.99e-04 | 882 | 119 | 11 | EFO_0008328 |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 1.04e-03 | 12 | 119 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | diabetic angiopathy (is_marker_for) | 1.04e-03 | 12 | 119 | 2 | DOID:11713 (is_marker_for) | |
| Disease | PARKINSON DISEASE, LATE-ONSET | 1.04e-03 | 12 | 119 | 2 | C3160718 | |
| Disease | event free survival time, type 1 diabetes mellitus, autoantibody measurement | 1.04e-03 | 12 | 119 | 2 | EFO_0000482, EFO_0004866, MONDO_0005147 | |
| Disease | disks large homolog 3 measurement | 1.04e-03 | 12 | 119 | 2 | EFO_0802472 | |
| Disease | pain | 1.22e-03 | 196 | 119 | 5 | EFO_0003843 | |
| Disease | corpus callosum posterior volume measurement | 1.22e-03 | 52 | 119 | 3 | EFO_0010298 | |
| Disease | Drug habituation | 1.23e-03 | 115 | 119 | 4 | C0013170 | |
| Disease | Drug abuse | 1.23e-03 | 115 | 119 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 1.23e-03 | 115 | 119 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 1.23e-03 | 115 | 119 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 1.23e-03 | 115 | 119 | 4 | C0013222 | |
| Disease | Drug Dependence | 1.23e-03 | 115 | 119 | 4 | C1510472 | |
| Disease | Substance Dependence | 1.23e-03 | 115 | 119 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 1.23e-03 | 115 | 119 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.23e-03 | 115 | 119 | 4 | C0029231 | |
| Disease | Substance abuse problem | 1.27e-03 | 116 | 119 | 4 | C0740858 | |
| Disease | caudate volume change measurement | 1.42e-03 | 14 | 119 | 2 | EFO_0021491 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 1.49e-03 | 121 | 119 | 4 | EFO_0008595, EFO_0020943 | |
| Disease | Adenocarcinoma of lung (disorder) | 1.52e-03 | 206 | 119 | 5 | C0152013 | |
| Disease | diastolic blood pressure, systolic blood pressure | 1.61e-03 | 670 | 119 | 9 | EFO_0006335, EFO_0006336 | |
| Disease | Lymphoma, Follicular, Grade 2 | 1.64e-03 | 15 | 119 | 2 | C1956132 | |
| Disease | Lymphoma, Follicular, Grade 3 | 1.64e-03 | 15 | 119 | 2 | C1956131 | |
| Disease | Lymphoma, Follicular, Grade 1 | 1.64e-03 | 15 | 119 | 2 | C1956130 | |
| Disease | Lymphoma, Large-Cell, Follicular | 1.64e-03 | 15 | 119 | 2 | C0079745 | |
| Disease | Lymphoma, Small Cleaved-Cell, Follicular | 1.64e-03 | 15 | 119 | 2 | C0079765 | |
| Disease | Lymphoma, Mixed-Cell, Follicular | 1.64e-03 | 15 | 119 | 2 | C0079758 | |
| Disease | obesity (implicated_via_orthology) | 1.83e-03 | 215 | 119 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | retinal layer thickness measurement | 1.85e-03 | 60 | 119 | 3 | EFO_0600002 | |
| Disease | DiGeorge Syndrome | 1.87e-03 | 16 | 119 | 2 | C0012236 | |
| Disease | Schizoaffective disorder-bipolar type | 1.87e-03 | 16 | 119 | 2 | EFO_0009965 | |
| Disease | CONOTRUNCAL ANOMALY FACE SYNDROME | 1.87e-03 | 16 | 119 | 2 | C0795907 | |
| Disease | Shprintzen syndrome | 1.87e-03 | 16 | 119 | 2 | C0220704 | |
| Disease | Ischemic stroke | 2.06e-03 | 324 | 119 | 6 | HP_0002140 | |
| Disease | banks of the superior temporal sulcus volume measurement | 2.11e-03 | 17 | 119 | 2 | EFO_0010286 | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 2.13e-03 | 63 | 119 | 3 | DOID:0050866 (is_marker_for) | |
| Disease | CCL5 measurement | 2.23e-03 | 64 | 119 | 3 | EFO_0005117 | |
| Disease | total blood protein measurement | 2.34e-03 | 449 | 119 | 7 | EFO_0004536 | |
| Disease | noggin measurement | 2.37e-03 | 18 | 119 | 2 | EFO_0021995 | |
| Disease | DiGeorge syndrome (implicated_via_orthology) | 2.64e-03 | 19 | 119 | 2 | DOID:11198 (implicated_via_orthology) | |
| Disease | serum alanine aminotransferase measurement | 2.77e-03 | 869 | 119 | 10 | EFO_0004735 | |
| Disease | mean platelet volume | FOLH1 PLXND1 SRCAP LRCH1 MEF2C ZMAT3 METTL13 TOX4 ATXN2 BAZ2A GP1BA | 2.82e-03 | 1020 | 119 | 11 | EFO_0004584 |
| Disease | Lymphoma, Follicular | 2.92e-03 | 20 | 119 | 2 | C0024301 | |
| Disease | Parkinson disease | 3.53e-03 | 22 | 119 | 2 | cv:C0030567 | |
| Disease | platelet component distribution width | 3.56e-03 | 755 | 119 | 9 | EFO_0007984 | |
| Disease | parental longevity | 3.96e-03 | 494 | 119 | 7 | EFO_0007796 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SKPPFQTNPSPEMVS | 666 | Q4LE39 | |
| PNCPAVPFSVTVPDM | 986 | Q9HCE0 | |
| SGPTSPSEMPDQFPA | 326 | O60239 | |
| PSEMPDQFPAVVRPG | 331 | O60239 | |
| PAMKSSPPPFIATQV | 791 | O60885 | |
| PGTFMRSDPFVPPAA | 201 | O43823 | |
| KTSPPPTSQMVEFPV | 1851 | Q8IZF6 | |
| FEVMPNGPPSFFTSP | 176 | Q9UIF9 | |
| PSAMPPSGGVQTVPI | 1131 | Q68CP9 | |
| MSPAGFPSVARTQPP | 1916 | Q92793 | |
| GSVTITGQPMTFPPE | 451 | Q5ZPR3 | |
| TAQTPEAGTSQPMPP | 601 | Q9HBB8 | |
| GTAQTPEPGTSQPMP | 631 | Q9HBB8 | |
| PPPPLQTSSGAEVMD | 36 | Q8WYQ5 | |
| TPIPCSEFPMGIDPT | 651 | Q5T5Y3 | |
| ESGFPTKMPPQPRTT | 286 | P50281 | |
| FGMDAGSPLVVPPPT | 561 | Q5JR59 | |
| AATVVPPMVGGPPFV | 106 | Q9BTD8 | |
| FGCMPPQVVTPPRES | 401 | P98160 | |
| PPYVMQPTGAVITPT | 306 | Q6XE24 | |
| GAGPQEPTQTPPTMT | 546 | Q7Z6P3 | |
| AGPQEPTQTPPTMAE | 756 | Q7Z6P3 | |
| GSIFPMSVPDVPPSI | 936 | Q14571 | |
| MEGSPIPVLTVPTAP | 1 | Q15124 | |
| VNVPIPVPLPMFSFT | 471 | Q02252 | |
| PIGTPPKQMAVPSFT | 191 | Q86TB9 | |
| SPPEMVGQRVPSAPG | 1801 | P78559 | |
| CGMPLTPPTSPEQAI | 321 | Q71F56 | |
| PPQSPQEESFSPTAM | 171 | P43364 | |
| AMPVPTTPEFQSPVT | 1691 | Q14676 | |
| PAVAPTTQTPPVAMV | 401 | Q9H3P2 | |
| QPVRMATFPGPGSSP | 131 | O43187 | |
| PFPEGTASNVTVMPP | 531 | O95835 | |
| MVNPGSSSQPPPVTA | 1 | P61968 | |
| PGETPPLSPIDMESQ | 236 | P05412 | |
| EAMVPSVCFTVPPPN | 931 | Q03001 | |
| PTEAVAMPIPAASPT | 716 | Q99700 | |
| TSPRPQAQPSPSMVG | 936 | Q99700 | |
| NIVTTVTPPGTPPMR | 266 | Q6VAB6 | |
| DIVPPFSAFSPQGMP | 156 | Q04609 | |
| MATVEPETTPTPNPP | 1 | P06730 | |
| MGEPAFTSFPSPPVL | 1 | A6NJ08 | |
| AAPPAEPVTVFPSML | 166 | Q9Y4D7 | |
| GFNPRMPTFPSTEPI | 171 | O00443 | |
| SDPVFKAVPVPNMTP | 401 | Q6P996 | |
| DPVFKAVPVPNMTPS | 401 | Q6P474 | |
| SVPPSPTFSEPGMVG | 46 | P54845 | |
| PMFRNVPTANPTEPG | 1536 | Q9Y4C0 | |
| MATPGSEPQPFVPAL | 1 | Q9Y2L9 | |
| MEVPQPEPAPGSALS | 1 | P30305 | |
| VPPPNFEMPVSIPVS | 136 | Q06413 | |
| MDPAAPAPVAGFPAV | 101 | Q96FT7 | |
| MSGEPGQTSVAPPPE | 1 | Q9BRT3 | |
| MPVPDSESVFIIPGS | 816 | Q9BXW6 | |
| MGEPAFTSFPSPPVL | 1 | A6NE82 | |
| PTFQPVFSSMGPPAS | 746 | A8CG34 | |
| TAPTFQPVFSSMGPP | 351 | A6NF01 | |
| QPVFSSMGPPASVPL | 356 | A6NF01 | |
| FQPVFSSMGPPASVP | 771 | Q96HA1 | |
| SPMVFAQPTSVPPKE | 526 | Q8IZD4 | |
| PPEVMSEQSVGGPPE | 1581 | Q9Y2I7 | |
| QFPVTLEPMPPGEGA | 281 | P87889 | |
| QFPVTLEPMPPGEGA | 281 | Q9YNA8 | |
| QFPVTLEPMPPGEGA | 281 | P63145 | |
| QFPVTLEPMPPGEGA | 281 | Q7LDI9 | |
| QFPVTLEPMPPGEGA | 281 | P63130 | |
| QFPVTLEPMPPGEGA | 281 | P62685 | |
| QFPVTLEPMPPGEGA | 281 | P63126 | |
| VATPSPAPGVNESPM | 301 | Q96DF8 | |
| PFFGSAAPIMTNPPV | 481 | Q8N960 | |
| PDGPPMDVTLQPVTS | 986 | Q8TD84 | |
| VEPPSVTPDTPATMF | 376 | Q8N3K9 | |
| SVMPPTITGFKPNAP | 1281 | Q5VT06 | |
| NGSEPGASMPPPFSV | 216 | P48664 | |
| TPPTQAQPAMTPASA | 96 | Q674R7 | |
| PTTSEPVPEPAPNMT | 386 | P07359 | |
| MQEAPAALPTEPGPS | 1 | Q9ULV5 | |
| VKTPIPMSFQPVPGG | 981 | Q9ULK0 | |
| PMSFQPVPGGVLPEA | 986 | Q9ULK0 | |
| MPPPAFPVTGIKTES | 521 | Q7Z7F0 | |
| SQPPAVCPPVVFMGT | 296 | Q13118 | |
| PTLGMSCPPPAFVEQ | 581 | Q8N6R0 | |
| VATGPMTPQAAAPPA | 871 | Q7Z2K8 | |
| PINTPPTPSSPFEDM | 276 | P39059 | |
| AVSLTPPGQEFPPAM | 466 | P18858 | |
| PVQSVSPAVPTPPSM | 861 | Q5VV67 | |
| MGEPAFTSFPSPPVL | 1 | A6NDZ8 | |
| PAPNFAMPVTVPVSN | 136 | Q14814 | |
| PRVTTGPTPFSTMPN | 446 | Q9BVL2 | |
| APPATPVMVPDSAVA | 271 | Q9UBD0 | |
| PMQNPVSASPVPSGT | 586 | Q9UQC2 | |
| TMPVNTIIPTSQFPP | 561 | Q92750 | |
| MSASASVGGPVPQPP | 1 | Q9P2Y5 | |
| TVTLPPASETFPPGM | 146 | Q9BZJ3 | |
| GPDAPFTTGVMVFTP | 156 | Q5T2D2 | |
| SGMPGVSLTPPVFVF | 186 | Q9ULS5 | |
| PGEPSDMLASVPPFV | 646 | Q7LBE3 | |
| MPVQVTPPRGAFSPG | 1021 | Q15788 | |
| IVLPPVFMPFSSPQG | 651 | Q8NE18 | |
| TLSPGPMTFSEPFGP | 201 | Q6ZUB1 | |
| MNPGFQPPITPDVET | 321 | P40879 | |
| QTPVPVMAPSSTPGT | 1626 | Q6ZRS2 | |
| PMPTPAQPAFISTTQ | 811 | Q96KW2 | |
| AMPTSEAPQPAVPAP | 386 | Q6Q759 | |
| QFPVTLEPMPPGEGA | 281 | P63128 | |
| MSSAGPGFPQAVPPT | 396 | O95081 | |
| PSPTQHPVSMPVGGT | 1986 | A4UGR9 | |
| QAVPGPGPMTPESAL | 101 | A0A494C1R9 | |
| MSEEPGPEQAATPPV | 41 | Q96IQ9 | |
| TADGQMQPVPFPPDA | 451 | Q04724 | |
| VPPGNDPVSPAMVRS | 236 | O94966 | |
| QAVPGPGPMTPESAL | 101 | P0CV99 | |
| IQASIFPPPSPAPMT | 386 | P60852 | |
| SVPPPPPSAFAEMGS | 1296 | O75970 | |
| EDTPPIVSQFPGTMA | 486 | Q9P246 | |
| NQMAVTPFPVPSSSP | 1326 | Q8NI35 | |
| SPQGAMTPGIPIFSP | 16 | P20226 | |
| PKPTVMGEPFTVNPA | 706 | O15014 | |
| VPPTPAPMATSQPEE | 186 | Q9P1Z0 | |
| QVTPTPPVGSSYQPM | 791 | Q12968 | |
| STFSPAPRPEMPGTV | 1181 | Q92576 | |
| PDSVPVDSFPPAPSM | 351 | Q7Z7A4 | |
| ATVMPPAQGTPSAPA | 256 | Q8IYB5 | |
| PAAFQGFPSMGVPVP | 336 | Q8IYB5 | |
| SPTPAMAAVPTQPQS | 121 | Q53EL9 | |
| ASTAGPQPLMSEPPV | 176 | Q9BRR9 | |
| GTTLVPASEPPFIMA | 666 | P08922 | |
| LMEPPFLFTAVPPSG | 811 | Q8N398 | |
| ATPVVPVPPQMGSFK | 121 | Q9HA38 | |
| QSAFPPATFMPPVQT | 901 | O60315 | |
| PATFMPPVQTSIPGL | 906 | O60315 | |
| VTVSIANMAVSPPPP | 406 | O94900 | |
| LPPDVTTQSVMGFDP | 571 | Q9BQ70 | |
| MPVGRIECPSSPSFP | 1 | Q9H2Y7 | |
| SQTPSPPPMATVDPA | 311 | O94842 | |
| RNPASVEPTMPGTGP | 1526 | Q562E7 | |
| ERPGTNSTGPAPMAP | 411 | Q13263 | |
| DGPPSQAAAPMATPT | 71 | Q6UXF1 | |
| DPANPSPVMPGIATS | 1031 | Q70EL1 | |
| PTFVAPPQMPIIPAS | 1161 | Q7Z570 | |
| PSPMRFTFPQAVGEP | 2531 | O14686 | |
| QENPTPPSPFGSMIT | 591 | Q9NQX4 | |
| VETQNPSFSPPSPMG | 981 | Q5VU43 |